<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">39800</article-id><article-id pub-id-type="doi">10.7554/eLife.39800</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title><italic>Plasmodium</italic>-specific atypical memory B cells are short-lived activated B cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-116446"><name><surname>Pérez-Mazliah</surname><given-names>Damián</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2156-2585</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-117065"><name><surname>Gardner</surname><given-names>Peter J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4940-2639</contrib-id><email>petegardner.uk@gmail.com</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-117070"><name><surname>Schweighoffer</surname><given-names>Edina</given-names></name><email>Edina.Schweighoffer@crick.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-117066"><name><surname>McLaughlin</surname><given-names>Sarah</given-names></name><email>sarah.manni@crick.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-117067"><name><surname>Hosking</surname><given-names>Caroline</given-names></name><email>Caroline.Hosking@crick.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-117068"><name><surname>Tumwine</surname><given-names>Irene</given-names></name><email>Irene.Tumwine@crick.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-30177"><name><surname>Davis</surname><given-names>Randall S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1906-8219</contrib-id><email>rsdavis@uab.edu</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-117069"><name><surname>Potocnik</surname><given-names>Alexandre J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4730-8593</contrib-id><email>alexandre.potocnik@ed.ac.uk</email><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42326"><name><surname>Tybulewicz</surname><given-names>Victor LJ</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2439-0798</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-116450"><name><surname>Langhorne</surname><given-names>Jean</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2257-9733</contrib-id><email>Jean.Langhorne@crick.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>The Francis Crick Institute</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution>MRC National Institute for Medical Research</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Department of Medicine</institution><institution>University of Alabama at Birmingham</institution><addr-line><named-content content-type="city">Birmingham</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Department of Microbiology</institution><institution>University of Alabama at Birmingham</institution><addr-line><named-content content-type="city">Birmingham</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Department of Biochemistry and Molecular Genetics</institution><institution>University of Alabama at Birmingham</institution><addr-line><named-content content-type="city">Birmingham</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">School of Biological Sciences</institution><institution>The University of Edinburgh</institution><addr-line><named-content content-type="city">Edinburgh</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Batista</surname><given-names>Facundo D</given-names></name><role>Reviewing Editor</role><aff><institution>Ragon Institute of MGH, MIT and Harvard</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Nussenzweig</surname><given-names>Michel C</given-names></name><role>Senior Editor</role><aff><institution>The Rockefeller University</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>02</day><month>11</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e39800</elocation-id><history><date date-type="received" iso-8601-date="2018-07-04"><day>04</day><month>07</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-10-31"><day>31</day><month>10</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Pérez-Mazliah et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Pérez-Mazliah et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-39800-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.39800.001</object-id><p>A subset of atypical memory B cells accumulates in malaria and several infections, autoimmune disorders and aging in both humans and mice. It has been suggested these cells are exhausted long-lived memory B cells, and their accumulation may contribute to poor acquisition of long-lasting immunity to certain chronic infections, such as malaria and HIV. Here, we generated an immunoglobulin heavy chain knock-in mouse with a BCR that recognizes MSP1 of the rodent malaria parasite, <italic>Plasmodium chabaudi</italic>. In combination with a mosquito-initiated <italic>P. chabaudi</italic> infection, we show that <italic>Plasmodium</italic>-specific atypical memory B cells are short-lived and disappear upon natural resolution of chronic infection. These cells show features of activation, proliferation, DNA replication, and plasmablasts. Our data demonstrate that <italic>Plasmodium</italic>-specific atypical memory B cells are not a subset of long-lived memory B cells, but rather short-lived activated cells, and part of a physiologic ongoing B-cell response.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>atypical memory B cells</kwd><kwd>age-associated B cells</kwd><kwd>Plasmodium</kwd><kwd>malaria</kwd><kwd>mosquito</kwd><kwd>FCRL5</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>AI110553</award-id><principal-award-recipient><name><surname>Davis</surname><given-names>Randall S</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>FC001101 and FC001194</award-id><principal-award-recipient><name><surname>Tybulewicz</surname><given-names>Victor LJ</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>FC001101 and FC001194</award-id><principal-award-recipient><name><surname>Tybulewicz</surname><given-names>Victor LJ</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>FC001101 and FC001194</award-id><principal-award-recipient><name><surname>Tybulewicz</surname><given-names>Victor LJ</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>FC001101</award-id><principal-award-recipient><name><surname>Langhorne</surname><given-names>Jean</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>FC001101</award-id><principal-award-recipient><name><surname>Langhorne</surname><given-names>Jean</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>FC001101</award-id><principal-award-recipient><name><surname>Langhorne</surname><given-names>Jean</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Plasmodium-specific atypical memory B cells generated to naturally (mosquito) transmitted rodent malaria infection are short-lived activated B cells, and do not prevent resolution of infection or generation of long-lived memory.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Atypical memory B cells (AMB) are an unusual B-cell subset detected in both mouse models and humans in the context of certain infections and autoimmune disorders, including HIV, HCV, tuberculosis, malaria, rheumatoid arthritis and systemic lupus erythematosus, and accumulated with age (<xref ref-type="bibr" rid="bib31">Knox et al., 2017b</xref>; <xref ref-type="bibr" rid="bib41">Naradikian et al., 2016a</xref>; <xref ref-type="bibr" rid="bib54">Portugal et al., 2017</xref>; <xref ref-type="bibr" rid="bib58">Rubtsov et al., 2017</xref>). In the context of infections, AMB were first described in HIV-viremic subjects, and termed tissue-like memory B cells, due to their similarity to an FCRL4-expressing memory B-cell subset found in human tonsillar tissues (<xref ref-type="bibr" rid="bib20">Ehrhardt et al., 2005</xref>; <xref ref-type="bibr" rid="bib39">Moir et al., 2008</xref>). In addition to FCRL4, these cells express relatively high levels of other potentially inhibitory receptors including CD22, CD85j, CD85k, LAIR-1, CD72, and PD-1, and show a profile of trafficking receptors including expression of CD11b, CD11c and CXCR3, consistent with migration to inflamed tissues. They are antigen-experienced class-switched B cells, which lack the expression of CD21 and the hallmark human memory B-cell marker CD27. Further studies demonstrated the expression of the transcription factor T-bet and the cytokine IFNγ by these cells, also characteristic of Th1 CD4<sup>+</sup> T cells (<xref ref-type="bibr" rid="bib31">Knox et al., 2017b</xref>; <xref ref-type="bibr" rid="bib48">Obeng-Adjei et al., 2017</xref>; <xref ref-type="bibr" rid="bib54">Portugal et al., 2017</xref>). Due to their poor functional capacity upon in vitro re-stimulation with BCR ligands, AMB were characterized as dysfunctional B cells, and increased frequencies of these cells was proposed to be a consequence of B-cell exhaustion driven by chronic inflammation and stimulation, drawing parallels with T-cell exhaustion during chronic viral infections (<xref ref-type="bibr" rid="bib39">Moir et al., 2008</xref>; <xref ref-type="bibr" rid="bib53">Portugal et al., 2015</xref>; <xref ref-type="bibr" rid="bib65">Sullivan et al., 2015</xref>). It has been hypothesized that expansion of AMB might contribute to the mechanisms driving autoimmune disorders and deficiencies in acquisition of immunity to chronic infections. However, due to lack of good tools and animal models to analyze antigen-specific atypical B cells in greater depth, many of these concepts remain speculative.</p><p>Several studies suggest that AMB might contribute to poor acquisition of long-term immunity to <italic>Plasmodium</italic> infection (<xref ref-type="bibr" rid="bib24">Illingworth et al., 2013</xref>; <xref ref-type="bibr" rid="bib53">Portugal et al., 2015</xref>; <xref ref-type="bibr" rid="bib65">Sullivan et al., 2015</xref>; <xref ref-type="bibr" rid="bib66">Sullivan et al., 2016</xref>; <xref ref-type="bibr" rid="bib73">Weiss et al., 2011</xref>; <xref ref-type="bibr" rid="bib71">Weiss et al., 2009</xref>; <xref ref-type="bibr" rid="bib72">Weiss et al., 2010</xref>). Indeed, some studies demonstrated that in the absence of constant re-exposure, <italic>Plasmodium</italic>-specific serum antibody levels rapidly wane, and full protection from clinical symptoms is lost, suggesting that B-cell memory is functionally impaired (<xref ref-type="bibr" rid="bib52">Portugal et al., 2013</xref>). However, others have reported long-lasting maintenance of <italic>Plasmodium</italic>-specific antibodies and/or memory B cells in settings of differing malaria endemicity, and similar responses are also observed in mouse malaria models (<xref ref-type="bibr" rid="bib18">Dorfman et al., 2005</xref>; <xref ref-type="bibr" rid="bib43">Ndungu et al., 2009</xref>; <xref ref-type="bibr" rid="bib45">Ndungu et al., 2013</xref>; <xref ref-type="bibr" rid="bib44">Ndungu et al., 2012</xref>; <xref ref-type="bibr" rid="bib74">Wipasa et al., 2010</xref>). Moreover, it has been shown that BCRs cloned from <italic>P. falciparum</italic>-specific AMB from malaria-exposed adults encode <italic>P. falciparum</italic>-specific IgG antibodies, which could contribute to <italic>P. falciparum</italic>-specific IgG antibodies in serum (<xref ref-type="bibr" rid="bib40">Muellenbeck et al., 2013</xref>). These authors proposed that <italic>P. falciparum</italic>-specific AMB do not prevent, but rather contribute to the control of <italic>Plasmodium</italic> infection. These apparently contradictory results may reflect the fact that some studies were performed on the general peripheral blood B-cell pool and others focused on <italic>Plasmodium</italic>-specific B cells. In determining a role for these cells in a chronic infection it would be important to follow antigen-specific responses and to distinguish these from non-specific polyclonal B cell activation.</p><p>The study of the development of AMB is challenging and requires suitable mouse models, which allow for identification and isolation of antigen-specific B cells that exist often at very low frequency. Here, we generated a knock-in transgenic mouse with a high frequency of B cells specific to the 21 kDa C-terminal fragment of <italic>Plasmodium chabaudi</italic> Merozoite Surface Protein 1 (MSP1<sub>21</sub>), to investigate memory B cells generated following mosquito-transmission of the rodent malaria, <italic>P. chabaudi</italic>. We identified a CD11b<sup>+</sup>CD11c<sup>+</sup>FCRL5<sup>hi</sup> subset of MSP1<sub>21</sub>-specific B cells during the chronic infection with phenotypical and transcriptional features strikingly similar to those of human AMB. These AMB disappeared as the infection progressed, leaving a CD11b<sup>—</sup>CD11c<sup>—</sup>FCRL5<sup>hi</sup> MSP1<sub>21</sub>-specific B-cell compartment with characteristics of long-lived classical memory B cells (B<sub>mem</sub>) after the resolution of the infection. These short-lived MSP1<sub>21</sub>-specific AMB were also generated in response to immunization, suggesting they may be a normal but transient component of a B-cell response to antigen. In this chronic <italic>P. chabaudi</italic> infection, it appears that AMB require ongoing antigenic stimulation driven by the sub-patent infection to persist, and do not represent a true long-lived ‘memory’ B cell subset. Moreover, we show that generation of <italic>Plasmodium</italic>-specific AMB does not prevent the generation of <italic>Plasmodium</italic>-specific B<sub>mem</sub>, and does not prevent resolution of the infection.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Generation of an immunoglobulin heavy chain knock-in transgenic mouse model to study <italic>Plasmodium</italic>-specific B cell responses</title><p>To study Plasmodium-specific B cell responses in a rodent malaria model, we generated an <italic>Igh</italic><sup>NIMP23/+</sup> mouse strain on the C57BL/6J background (Materials and methods and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p><p>The <italic>Igh</italic><sup>NIMP23/+</sup> mice were healthy, with no unusual behavioral or physical characteristics. There were no alterations in total cellularity, pro-B, pre-B, immature B, mature B, total B220<sup>+</sup>CD19<sup>+</sup> B cells, and plasma cells in the bone marrow (<xref ref-type="fig" rid="fig1">Figure 1A–B</xref>), and no alterations in number of T1, T2, T3, follicular, marginal zone, germinal center B cells, plasmablasts, plasma cells, and total cellularity in the spleen of <italic>Igh</italic><sup>NIMP23/+</sup> mice (<xref ref-type="fig" rid="fig1">Figure 1C–D</xref>) (<xref ref-type="bibr" rid="bib61">Sen et al., 1990</xref>; <xref ref-type="bibr" rid="bib76">Young et al., 1994</xref>). Importantly, The <italic>Igh</italic><sup>NIMP23/+</sup> mice had a greatly increased frequency of B cells specific for MSP1<sub>21</sub> (approximately 60% of the total B-cell compartment), as demonstrated by flow cytometry analysis of splenocytes with a MSP1<sub>21</sub> fluorescent probe consisting of biotinylated recombinant MSP1<sub>21</sub> loaded on streptavidin-PE (<xref ref-type="fig" rid="fig1">Figure 1E–F</xref>). Thus, in this model, a recombinant light chain is not required to bring about specificity. This suggest that most endogenous light chains will pair with the NIMP23 heavy chain to generate a BCR with detectable binding to MSP1<sub>21</sub>.</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.39800.002</object-id><label>Figure 1.</label><caption><title>Analysis of total bone marrow and splenic B-cell populations in <italic>Igh</italic><sup>NIMP23/+</sup> and <italic>Igh</italic><sup>+/+</sup>littermates.</title><p>(<bold>A</bold>) Flow cytometry gating strategy to identify different B-cell populations in bone marrow of <italic>Igh</italic><sup>NIMP23/+</sup> mice. Arrows indicate flow of analysis. The same strategy was used for <italic>Igh</italic><sup>+/+</sup> littermates. (<bold>B</bold>) Percentages and numbers of different B-cell populations in bone marrow of <italic>Igh</italic><sup>NIMP23/+</sup> and <italic>Igh</italic><sup>+/+</sup> littermates as defined in (<bold>A</bold>). (<bold>C</bold>) Flow cytometry gating strategy to identify different B-cell populations in spleen of <italic>Igh</italic><sup>NIMP23/+</sup> mice. (<bold>D</bold>) Percentages and numbers of different B-cell populations in spleen of <italic>Igh</italic><sup>NIMP23/+</sup> and <italic>Igh</italic><sup>+/+</sup> littermates as defined in (<bold>C</bold>). Data are representative of two independent experiments with four mice per group. (<bold>E</bold>) Flow cytometry analysis of B cells obtained from spleen of <italic>Igh</italic><sup>+/+</sup> (left) and <italic>Igh</italic><sup>NIMP23/+</sup> (right) mice stained with anti-B220 and CD19 antibodies in combination with an MSP1<sub>21</sub> fluorescent probe. The gates show the frequency of B cells specific to MSP1<sub>21</sub>. (<bold>F</bold>) Frequencies of MSP1<sub>21</sub>-specific splenic B cells in <italic>Igh</italic><sup>NIMP23/+</sup> and wild-type <italic>Igh</italic><sup>+/+</sup> littermate controls (Mann Whitney U test). Data pooled from two independent experiments with 3–5 mice per group. Mann Whitney U test. *p&lt;0.05. Error bars are SEM.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-39800-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.39800.003</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Generation of <italic>Igh</italic><sup>NIMP23/+</sup>knock in mice.</title><p>Annotated DNA and corresponding amino acid sequence of VDJ<sub>H</sub><sup>NIMP23</sup> obtained from (<bold>A</bold>) gDNA including the Leader-V intron and (<bold>B</bold>) cDNA, of the NIMP23 hybridoma: start Methionine (Met) indicated by red star, intron splice donor and acceptor sites highlighted in red, dots indicate STOP codons, black bars indicate predicted complementarity determining regions according to the Kabat database (<xref ref-type="bibr" rid="bib25">Johnson and Wu, 2001</xref>) (<bold>C</bold>) IMGT/V-Quest mouse Ig database (Lefranc et al., 1999) comparative analysis result summary of the gDNA derived VDJ<sub>H</sub><sup>NIMP23</sup> sequence reveals the identity of the closest matching endogenous V and J genes (<bold>D</bold>) Schematic representation of (<italic>Igh</italic><sup>+</sup>) Endogenous IgH locus showing the 4 JH segments, the DQ52 element, the Igh intronic enhancer (E<sub>H</sub>), the switch region for the constant µ gene (<bold>S</bold>), and (below) targeting construct indicating 5’ and 3’ homology arms and the inverted loxP-neo<sup>r</sup>-loxP cassette and rearranged VDJ<sub>H</sub><sup>NIMP23</sup> variable heavy chain region gene of the NIMP23 hybridoma, replacing DQ52 and all four JH segments of the endogenous IgH gene. <italic>Igh</italic><sup>NIMP23neo</sup>: Targeted <italic>Igh</italic> locus after homologous recombination. <italic>Igh</italic><sup>NIMP23</sup>: Final allele after Cre-mediated removal of neo<sup>r</sup>.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-39800-fig1-figsupp1-v2"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.39800.004</object-id><label>Figure 1—figure supplement 2.</label><caption><title>Generation of mixed bone marrow chimera model with reduced precursor frequency of <italic>Igh</italic><sup>NIMP23<italic>/+ </italic></sup>B cells to study MSP1<sub>21</sub>-specific B cell responses during <italic>P. chabaudi</italic> infection.</title><p>(<bold>A</bold>) Experimental strategy to generate mixed bone marrow chimeric mice. (<bold>B</bold>) Numbers of different splenic B-cell populations defined by flow cytometry in <italic>Rag2<sup>-/-</sup></italic>.C57BL/6.SJL-<italic>Ptprc<sup>a</sup></italic> mice reconstituted with a mixture of <italic>Igh</italic><sup>NIMP23/+</sup> and C57BL/6.SJL-<italic>Ptprc<sup>a</sup></italic> bone marrow in a 10:90 ratio (NIMP23→ <italic>Rag2<sup>-/-</sup></italic>), and control mice reconstituted with C57BL/6.SJL-<italic>Ptprc<sup>a</sup></italic> bone marrow (WT→ <italic>Rag2<sup>-/-</sup></italic>). Mann Whitney U test. Error bars are SEM. Data are representative of two independent experiments with five mice per group. (<bold>C</bold>) Flow cytometry of B cells obtained from different tissues of NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice. Gates show frequencies of CD45.1<sup>+</sup>CD45.2<sup>-</sup> and CD45.1<sup>-</sup>CD45.2<sup>+</sup> (<bold>D</bold>) Flow cytometry of B cells obtained from spleen of NIMP23→<italic>Rag2<sup>-/-</sup></italic> and WT→<italic>Rag2<sup>-/-</sup></italic> control chimeric mice. Gates show frequencies of MSP1<sub>21</sub>-specific B cells as determined by CD45.2 vs MSP1<sub>21</sub> staining. (<bold>E</bold>) Frequencies of CD45.1<sup>-</sup>CD45.2<sup>+</sup> (black) and CD45.2<sup>+</sup>MSP1<sub>21</sub><sup>+</sup> (grey) B cells as gated in C and D, obtained from different organs of NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice. (<bold>F</bold>) Blood-stage <italic>P. chabaudi</italic> parasitemia following mosquito transmission in NIMP23→<italic>Rag2<sup>-/-</sup></italic> and WT→<italic>Rag2<sup>-/-</sup></italic> control chimeric mice. (<bold>G</bold>) Flow cytometry data showing frequencies of MSP1<sub>21</sub>-specific GC (CD38<sup>lo</sup>GL-7<sup>hi</sup>) and class-switched (IgD<sup>—</sup>IgG2b<sup>hi</sup>) B cells in the spleen of NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice before infection (day 0) and at day 35 post-mosquito transmitted <italic>P. chabaudi</italic> infection. (<bold>H</bold>) Numbers of MSP1<sub>21</sub>-specific B cells, GC and class-switched B cells in the spleen of NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice as gated in B and E. Mann Whitney U test. Error bars are SEM. Data representative of two independent experiments with 3–7 mice per group.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-39800-fig1-figsupp2-v2"/></fig></fig-group></sec><sec id="s2-2"><title>Increase in <italic>Plasmodium</italic>-specific B cells after mosquito transmission of <italic>P. chabaudi</italic></title><p>To investigate B cells in <italic>P. chabaudi</italic> infections, which last several weeks, and to avoid potential problems with activation arising from very high frequencies of MSP1-specific B cells, we reduced the precursor frequency of MSP1<sub>21</sub>-specific B cells to match the natural level expected for antigen-specific B cells more closely, yet still readily detectable by flow cytometry. We generated mixed bone marrow (BM) chimeras by adoptively transferring a mixture of 10% bone marrow from either <italic>Igh</italic><sup>NIMP23/+</sup> or <italic>Igh</italic><sup>+/+</sup> mice (CD45.2<sup>+</sup>) together with 90% bone marrow from C57BL/6.SJL-<italic>Ptprc<sup>a</sup></italic> mice (CD45.1<sup>+</sup>) into sub-lethally irradiated <italic>Rag2<sup>-/-</sup></italic>.C57BL/6.SJL-<italic>Ptprc<sup>a</sup></italic> mice (CD45.1<sup>+</sup>) to generate NIMP23→<italic>Rag2<sup>-/-</sup></italic> and WT→<italic>Rag2<sup>-/-</sup></italic> bone marrow chimeric mice respectively (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A–B</xref>). In both types of chimeras, 2–3% of the B cells were CD45.2<sup>+</sup> and in NIMP23→<italic>Rag2<sup>-/-</sup></italic> mice approximately 1–2% of the B cells were MSP1<sub>21</sub>-specific (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C–E</xref>). No MSP1<sub>21</sub>-specific B cells were detected in the control WT→<italic>Rag2<sup>-/-</sup></italic> chimeras (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2D</xref>).</p><p>Infection of C57BL/6J <italic>wt</italic> mice with <italic>P. chabaudi</italic> by mosquito bite gives rise to a short (48 hr) pre-erythrocytic infection, followed by an acute blood parasitemia peaking approximately 10d post-transmission. Thereafter, the infection is rapidly controlled, reaching very low parasitemias by 15d post-transmission, with a subsequent prolonged (~90 d), but low-level chronic infection before parasite elimination (<xref ref-type="bibr" rid="bib9">Brugat et al., 2017</xref>; <xref ref-type="bibr" rid="bib63">Spence et al., 2013</xref>). NIMP23→<italic>Rag2<sup>-/-</sup></italic> mice infected with <italic>P. chabaudi</italic> by mosquito bite, showed a similar course of parasitemia to that of control WT→<italic>Rag2<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2F</xref>), and C57BL/6J <italic>wt</italic> mice (<xref ref-type="bibr" rid="bib9">Brugat et al., 2017</xref>; <xref ref-type="bibr" rid="bib63">Spence et al., 2013</xref>; <xref ref-type="bibr" rid="bib62">Spence et al., 2012</xref>). Importantly, the MSP1<sub>21</sub>-specific <italic>Igh</italic><sup>NIMP23/+</sup> B cells (CD45.2<sup>+</sup>MSP1<sub>21</sub><sup>+</sup>) in NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeras showed a robust response to the infection, as demonstrated by a dramatic increase in the proportions and numbers of GL-7<sup>+</sup>CD38<sup>lo</sup> germinal centers (GC) and IgG2b<sup>+</sup>IgD<sup>—</sup> class-switched B cells in the spleen at 35 days post-infection (dpi) (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2G–H</xref>).</p><p>Thus, we have generated a mouse model with detectable numbers of functional MSP1<sub>21</sub>-specific B cells capable of responding to <italic>P. chabaudi</italic> infection.</p></sec><sec id="s2-3"><title>Generation of <italic>Plasmodium</italic>-specific AMB after mosquito transmission of <italic>P. chabaudi</italic> infection</title><p>We investigated whether <italic>Plasmodium</italic>-specific AMB could be identified in mice during a blood-stage <italic>P. chabaudi</italic> infection. We selected a series of mouse homologues to human cell surface markers described on human AMB (<xref ref-type="bibr" rid="bib11">Charles et al., 2011</xref>; <xref ref-type="bibr" rid="bib29">Kardava et al., 2014</xref>; <xref ref-type="bibr" rid="bib28">Kardava et al., 2011</xref>; <xref ref-type="bibr" rid="bib30">Knox et al., 2017a</xref>; <xref ref-type="bibr" rid="bib36">Li et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Moir et al., 2008</xref>; <xref ref-type="bibr" rid="bib40">Muellenbeck et al., 2013</xref>; <xref ref-type="bibr" rid="bib53">Portugal et al., 2015</xref>; <xref ref-type="bibr" rid="bib60">Russell Knode et al., 2017</xref>; <xref ref-type="bibr" rid="bib65">Sullivan et al., 2015</xref>). Human AMB express CD11b, CD11c, Fc receptor-like (FCRL) 3–5, high levels of CD80, low levels of CD21, and are Ig class-switched. Mouse FCRL5 most closely resembles human FCRL3 and is the only mouse FCRL-family member which contains both ITIM and ITAM motifs in its cytoplasmic tail (<xref ref-type="bibr" rid="bib15">Davis, 2007</xref>; <xref ref-type="bibr" rid="bib14">Davis et al., 2004</xref>; <xref ref-type="bibr" rid="bib75">Won et al., 2006</xref>; <xref ref-type="bibr" rid="bib77">Zhu et al., 2013</xref>). Therefore, our flow cytometry panel for mouse AMB included antibodies against CD11b, CD11c, FCRL5, CD21, IgD, and also CD80 and CD273 which identify mouse B cells that are antigen-experienced and potentially memory cells (<xref ref-type="bibr" rid="bib2">Anderson et al., 2007</xref>; <xref ref-type="bibr" rid="bib69">Tomayko et al., 2010</xref>; <xref ref-type="bibr" rid="bib79">Zuccarino-Catania et al., 2014</xref>).</p><p>We detected an increased number of cells in a distinct CD11b<sup>+</sup>CD11c<sup>+</sup> MSP1<sub>21</sub>-specific B-cell subset at 28-35dpi, in the chronic phase of <italic>P. chabaudi</italic> infection (<xref ref-type="fig" rid="fig2">Figure 2A–B</xref>). This subset showed several AMB characteristics, including high expression of FCRL5 and low expression of CD21 and IgD (<xref ref-type="fig" rid="fig2">Figure 2C–E</xref>). In addition, the CD11b<sup>+</sup>CD11c<sup>+</sup> MSP1<sub>21</sub>-specific B-cell subset was enriched with cells expressing CD80 and CD273 (<xref ref-type="fig" rid="fig2">Figure 2C–E</xref>).</p><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.39800.005</object-id><label>Figure 2.</label><caption><title>Generation of MSP1<sub>21</sub>-specific AMB in response to mosquito transmitted <italic>P.chabaudi</italic> infection.</title><p>(<bold>A</bold>) Flow cytometry showing differential expression of CD11b and CD11c on splenic MSP1<sub>21</sub>-specific B cells from NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice before infection (day 0) and at 35 and 155dpi. (<bold>B</bold>) Numbers of splenic MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> AMB from NIMP23→<italic>Rag2<sup>-/-</sup></italic> during the course of mosquito transmitted <italic>P. chabaudi</italic> infection. Kruskal-Wallis test vs day 0. ****, p&lt;0.0001 (<bold>C</bold>) Flow cytometry showing expression of CD21/35, FCRL5, IgD, CD273 and CD80 on different subsets of splenic MSP1<sub>21</sub>-specific B cells from NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice defined based on CD11b and CD11c expression at 35dpi. (<bold>D</bold>) Geometric mean fluorescence intensity (MFI) of CD21/35, FCRL5, IgD, CD273 and CD80 expression on different subsets of splenic MSP1<sub>21</sub>-specific B cells from NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice defined based on CD11b and CD11c expression at 35dpi. (<bold>E</bold>) Frequencies of CD21/35, FCRL5, IgD, CD273 and CD80 positive cells among different subsets of splenic MSP1<sub>21</sub>-specific B cells from NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice defined based on CD11b and CD11c expression at 35dpi. Two-way ANOVA vs CD11b<sup>-</sup>CD11c<sup>-</sup> subset. *p&lt;0.05; **p&lt;0.01, ***p&lt;0.001; ****p&lt;0.0001. Error bars are SEM. Data pooled from three independent experiments with 3–5 mice per group.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-39800-fig2-v2"/></fig><p>We then explored whether this CD11b<sup>+</sup>CD11c<sup>+</sup> MSP1<sub>21</sub>-specific B cell subset was detected during the memory phase,that is after resolution of the infection. As it takes up to 90 days for a blood-stage <italic>P. chabaudi</italic> infection to be eliminated from C57BL/6J mice (<xref ref-type="bibr" rid="bib1">Achtman et al., 2007</xref>; <xref ref-type="bibr" rid="bib63">Spence et al., 2013</xref>), we measured these responses from 155dpi onwards. Unexpectedly, the numbers of CD11b<sup>+</sup>CD11c<sup>+</sup> MSP1<sub>21</sub>-specific B cells were not significantly higher than background level (<xref ref-type="fig" rid="fig2">Figure 2A–B</xref>).</p><p>These data demonstrate that a mosquito-borne infection with <italic>P. chabaudi</italic> generates <italic>Plasmodium</italic>-specific B cells resembling human AMB. However, these cells do not persist and are not detected above background level after parasite clearance.</p></sec><sec id="s2-4"><title>Transcriptome analysis confirms the AMB nature of CD11b<sup>+</sup>CD11c<sup>+</sup> MSP1<sub>21</sub>-specific B cells, and reveals a plasmablast-like signature for this subset</title><p>To gain a better understanding of the identity of the CD11b<sup>+</sup>CD11c<sup>+</sup> <italic>Plasmodium</italic>-specific B cell subset, we isolated both CD11b<sup>+</sup>CD11c<sup>+</sup> and CD11b<sup>-</sup>CD11c<sup>-</sup> MSP1<sub>21</sub>-specific B cells from spleens of <italic>P. chabaudi</italic>-infected NIMP23→<italic>Rag2<sup>-/-</sup></italic> mice (35dpi) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), and MSP1<sub>21</sub>-specific B cells from the spleen of naïve NIMP23→<italic>Rag2<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), by flow cytometric sorting, and performed an mRNAseq transcriptional analysis on the three populations.</p><p>We then selected a large series of key genes previously shown to be either up or downregulated on human AMB (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), and explored the expression of their mouse homologues on the three different B-cell subsets we sorted at day 35pi. The transcriptome of CD11b<sup>+</sup>CD11c<sup>+</sup> MSP1<sub>21</sub>-specific B cells highly resembled that of human AMB. A series of hallmark genes upregulated in human AMB were also upregulated in CD11b<sup>+</sup>CD11c<sup>+</sup> MSP1<sub>21</sub>-specific B cells, including IgG (<italic>Ighg2c</italic> and <italic>Ighg2b</italic>), <italic>Cxcr3</italic>, <italic>Tbx21</italic> (T-bet), <italic>Lair1</italic> and <italic>Fcrl5</italic> (<xref ref-type="fig" rid="fig3">Figure 3</xref>, genes in red boxes, and references in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). In addition, the MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> B-cell subset showed upregulation of <italic>Ifng</italic>, <italic>Aicda</italic>, a large array of inhibitory receptors [including <italic>Pd1</italic>, <italic>Cd72</italic>, <italic>Cd85k</italic>, <italic>Fcgr2b</italic> (CD32b), S<italic>iglece</italic>], antigen-experienced/memory markers [<italic>Cd80</italic>, <italic>Cd86</italic>, <italic>Nt5e</italic> (CD73) and high <italic>Cd38</italic>], and additional class-switched immunoglobulins (i.e. <italic>Igha</italic>, <italic>Ighg1</italic> and <italic>Ighg3</italic>), all of which have been shown to be upregulated on human AMB (<xref ref-type="fig" rid="fig3">Figure 3C–G</xref>, references in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). These cells also expressed Galectins (<italic>Lgals1</italic> and <italic>Lgals3</italic>), previously implicated in B-cell anergy (<xref ref-type="bibr" rid="bib13">Clark et al., 2007</xref>) (<xref ref-type="fig" rid="fig3">Figure 3H</xref>), and displayed a pro-apoptotic program (e.g. high expression of <italic>Fasl</italic>, and low expression of <italic>Bcl2</italic>) (<xref ref-type="fig" rid="fig3">Figure 3I</xref>). Interestingly, in agreement with data on human AMB, MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> B cells showed upregulation of <italic>Mki67</italic> (<xref ref-type="fig" rid="fig3">Figure 3J</xref>), indicative of proliferation, and had characteristics of plasmablasts and/or plasma cells, including upregulation of <italic>Cd138</italic>, <italic>Prdm1</italic> (<italic>Blimp1</italic>) and <italic>Xbp1</italic>, and low expression of <italic>Cxcr5</italic>, <italic>Pax5</italic>, and <italic>Bcl6</italic> (<xref ref-type="fig" rid="fig3">Figure 3B and K</xref>). However, these cells showed low expression of <italic>Irf4</italic> and <italic>S1p1</italic>, suggesting that they may be in a pre-plasmablast or pre-migratory plasma-cell stage (<xref ref-type="bibr" rid="bib26">Kabashima et al., 2006</xref>; <xref ref-type="bibr" rid="bib27">Kallies et al., 2007</xref>) (<xref ref-type="fig" rid="fig3">Figure 3K</xref>). Finally, and similar to human AMB, CD11b<sup>+</sup>CD11c<sup>+</sup> MSP1<sub>21</sub>-specific B cells showed low expression of <italic>Cd40</italic>, <italic>Cr2</italic> (CD21), <italic>Ms4a1</italic> (CD20), and <italic>Cd24a</italic> (<xref ref-type="fig" rid="fig3">Figure 3L</xref>).</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.39800.006</object-id><label>Figure 3.</label><caption><title>Transcriptome analysis of sorted splenic MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup>AMB.</title><p>MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> (AMB) and CD11b<sup>—</sup>CD11c<sup>—</sup> B cells were flow cytometry sorted from the spleen of NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice at 35dpi; MSP1<sub>21</sub>-specific B cells were flow cytometry sorted from the spleen of naïve NIMP23→<italic>Rag2<sup>-/-</sup></italic>, and these three B cell populations were submitted to mRNAseq analysis. The heat maps display level of expression of selected individual genes, organized in functional clusters related to (<bold>A</bold>) Fc receptor like molecules, (<bold>B</bold>) cell trafficking, (<bold>C</bold>) cytokines, (<bold>D</bold>) transcription factors, (<bold>E</bold>) inhibitory receptors, (<bold>F</bold>) antigen experience/memory, (<bold>G</bold>) immunoglobulins, (<bold>H</bold>) galectins, (<bold>I</bold>) apoptosis, (<bold>J</bold>) proliferation, (<bold>K</bold>) plasma cells/plasmablasts/germinal centers, (<bold>L</bold>) surface markers. Each column corresponds to data from an individual mouse (n = 5 35 dpi, n = 5 0 dpi).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-39800-fig3-v2"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.39800.007</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Gating strategy for the sorting of splenic MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> AMB and CD11b<sup>—</sup>CD11c<sup>—</sup> B cells at 35dpi.</title></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-39800-fig3-figsupp1-v2"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.39800.008</object-id><label>Figure 3—figure supplement 2.</label><caption><title>Profile of the Running <italic>ES</italic> Score and positions of GeneSet members on the rank ordered list for selected Reactome pathway gene sets.</title></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-39800-fig3-figsupp2-v2"/></fig></fig-group><p>We ran a Gene Set Enrichment Analysis (GSEA) (<xref ref-type="bibr" rid="bib64">Subramanian et al., 2005</xref>) with a gene list ranked according to their differential expression between MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> AMB sorted from infected mice and MSP1<sub>21</sub>-specific B cells sorted from naïve mice, using gene sets <italic>a priori</italic> obtained from Reactome (<xref ref-type="bibr" rid="bib22">Fabregat et al., 2018</xref>). Among the gene sets yielding the top 50 significant (fdr &lt;0.001) highest normalized enrichment score (<italic>NES</italic>) we obtained gene sets corresponding to cell cycle, DNA replication, generation/consumption of energy, regulation of apoptosis, activation of NF-κB on B cells, and downstream signaling events of the BCR (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). These data further corroborate the activated and proliferative nature of MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> AMB.</p><p>Taken together, these data demonstrate that CD11b<sup>+</sup>CD11c<sup>+</sup> MSP1<sub>21</sub>-specific mouse AMB present during the chronic phase of <italic>P. chabaudi</italic> infection are very similar to human AMB described in several chronic infections. In addition, this B-cell subset shows features of activation, proliferation, DNA replication and plasmablasts, resembling previous observations in human AMB (<xref ref-type="bibr" rid="bib40">Muellenbeck et al., 2013</xref>).</p></sec><sec id="s2-5"><title>Generation of <italic>Plasmodium</italic>-specific AMB in response to immunization</title><p>The occurrence of CD11b<sup>+</sup>CD11c<sup>+</sup> AMB might be a consequence of aberrant B-cell activation driven exclusively by certain pathogens. Alternatively, they might be part of a normal B-cell response, which is exacerbated by the persistent nature of certain infections. To test whether CD11b<sup>+</sup>CD11c<sup>+</sup>FCRL5<sup>+</sup> AMB could be generated in the absence of persistent infection, we immunized mice with MSP1<sub>21</sub>. A previous report had demonstrated the presence of CD11b<sup>+</sup>CD11c<sup>+</sup>Tbet<sup>+</sup> B-cells 24 hr post-immunization with R848, a TLR7/8 ligand (<xref ref-type="bibr" rid="bib59">Rubtsova et al., 2013</xref>). Therefore, we immunized <italic>Igh</italic><sup>NIMP23/+</sup> mice with R848 together with the antigen MSP1<sub>21</sub> and looked for the appearance of MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup>FCRL5<sup>+</sup> atypical B cells. We observed substantial numbers of MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> B cells in the spleens of <italic>Igh</italic><sup>NIMP23/+</sup> mice 24 hr post-immunization (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). These cells expressed increased levels of both FCRL5 and CD80 (<xref ref-type="fig" rid="fig4">Figure 4B–C</xref>) and did not display GC characteristics (<xref ref-type="fig" rid="fig4">Figure 4D</xref>), similar to the MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup>FCRL5<sup>+</sup> atypical B cells generated following <italic>Plasmodium</italic> infection. The MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> B cells observed after immunization appeared only transiently, as they could no longer be detected at 3 and 7d post-immunization (<xref ref-type="fig" rid="fig4">Figure 4A and E</xref>).</p><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.39800.009</object-id><label>Figure 4.</label><caption><title>Generation of splenic MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup>AMB in response to immunization.</title><p>(<bold>A</bold>) Flow cytometry showing differential expression of CD11b and CD11c on splenic MSP1<sub>21</sub>-specific B cells from <italic>Igh</italic><sup>NIMP23/+</sup> mice before immunization (day 0) and at days 1 and 3 post-immunization with R848 and MSP1<sub>21</sub>. (<bold>B</bold>) Flow cytometry showing expression of FCRL5 and CD80 on different subsets of splenic MSP1<sub>21</sub>-specific B cells from <italic>Igh</italic><sup>NIMP23/+</sup> defined based on CD11b and CD11c expression at day one post-immunization and naïve mice. (<bold>C</bold>) Geometric MFI of FCRL5 and CD80 expression on different subsets of splenic MSP1<sub>21</sub>-specific B cells from <italic>Igh</italic><sup>NIMP23/+</sup> defined based on CD11b and CD11c expression at day one post-immunization. Two-way ANOVA vs CD11b<sup>—</sup>CD11c<sup>—</sup> subset. ****p&lt;0.0001. (<bold>D</bold>) Flow cytometry of CD38 vs GL-7 (GC markers) on CD11b<sup>+</sup>CD11c<sup>+</sup> MSP1<sub>21</sub>-specific B cells from <italic>Igh</italic><sup>NIMP23/+</sup> at day one post-immunization. (<bold>E</bold>) Numbers of splenic CD11b<sup>+</sup>CD11c<sup>+</sup> MSP1<sub>21</sub>-specific B cells from <italic>Igh</italic><sup>NIMP23/+</sup> during the course of immunization. Kruskal-Wallis test compared to day 0. **p&lt;0.01. Error bars are SEM. Data pooled from three independent experiments with 3–5 mice per group.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-39800-fig4-v2"/></fig><p>These data demonstrate that MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> AMB with no functional characteristics of memory B cells can be generated independently of the infection and the presence of the pathogen, and that they are short-lived cells.</p></sec><sec id="s2-6"><title><italic>Plasmodium</italic>-specific CD80<sup>+</sup>CD273<sup>+</sup> B<sub>mem</sub> are generated and persist after resolution of <italic>P. chabaudi</italic> infection</title><p>Identification of mouse B<sub>mem</sub> by flow cytometry originally relied on detecting B cells that had undergone Ig class-switching from IgM to IgG, and that did not express GC markers (i.e. IgG<sup>+</sup>CD38<sup>hi</sup>GL-7<sup>lo</sup>) (<xref ref-type="bibr" rid="bib33">Lalor et al., 1992</xref>; <xref ref-type="bibr" rid="bib56">Ridderstad and Tarlinton, 1998</xref>). More recently, this set of markers has been extended to include CD80, CD273 (PD-L2) and CD73, with CD273 and CD80 being the most useful to discriminate memory from naïve B cells (<xref ref-type="bibr" rid="bib69">Tomayko et al., 2010</xref>; <xref ref-type="bibr" rid="bib79">Zuccarino-Catania et al., 2014</xref>). In combination, these markers allow the identification of different subsets of switched as well as non-class switched (i.e. IgM/D<sup>+</sup>) B<sub>mem</sub>. Therefore, we used cell surface expression of CD80 and CD273 on MSP1<sub>21</sub>-specific B cells to identify B<sub>mem</sub> during and after resolution of P. <italic>chabaudi</italic> infection.</p><p>MSP1<sub>21</sub>-specific B cells from spleens of naïve NIMP23→<italic>Rag2<sup>-/-</sup></italic> mixed BM chimeras showed little expression of either CD80 or CD273 (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). By contrast, CD80<sup>+</sup>CD273<sup>+</sup>, CD80<sup>+</sup>CD273<sup>—</sup> and CD80<sup>—</sup>CD273<sup>+</sup> MSP1<sub>21</sub>-specific B cells, both class-switched (IgM/D<sup>lo</sup>) and non-class-switched (IgM/D<sup>hi</sup>), were readily detected above background levels at 28-35dpi in <italic>P. chabaudi</italic>-infected NIMP23→<italic>Rag2<sup>-/-</sup></italic> mixed BM chimeras (<xref ref-type="fig" rid="fig5">Figure 5B and D</xref>). After resolution of infection (155-170dpi), the numbers of CD80<sup>+</sup>CD273<sup>+</sup> and CD80<sup>+</sup>CD273<sup>—</sup> MSP1<sub>21</sub>-specific B cells were either sustained or increased, while the CD80<sup>—</sup>CD273<sup>+</sup> population decreased, compared with 28-35dpi (<xref ref-type="fig" rid="fig5">Figure 5A–D</xref>). All three MSP1<sub>21</sub>-specific B<sub>mem</sub> subsets showed high CD38 expression (<xref ref-type="fig" rid="fig5">Figure 5E,F</xref>). Importantly, the MSP1<sub>21</sub>-specific GC B cells detected at 28-35dpi did not express either CD80 or CD273, further distinguishing GC from memory and atypical memory <italic>P. chabaudi</italic>-specific B-cell subsets (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). No MSP1<sub>21</sub>-specific GC B cells were detected above background level after resolution of the infection (<xref ref-type="fig" rid="fig5">Figure 5H</xref>). Finally, and in accordance with <xref ref-type="fig" rid="fig3">Figure 3</xref>, approximately 70% of the MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> AMB observed at days 28-35pi expressed either CD80, CD273 or a combination of both (<xref ref-type="fig" rid="fig5">Figure 5I</xref>).</p><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.39800.010</object-id><label>Figure 5.</label><caption><title>Detection of MSP1<sub>21</sub>-specific B<sub>mem</sub> after resolution of <italic>P.chabaudi</italic> infection.</title><p>(<bold>A</bold>), (<bold>B</bold>) and (<bold>C</bold>) Flow cytometry showing gating strategy to identify splenic IgM/D<sup>hi</sup> and IgM/D<sup>lo</sup> CD273<sup>+</sup> and/or CD80<sup>+</sup> MSP1<sub>21</sub>-specific B<sub>mem</sub> in NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice before infection (day 0), at 35 and 155dpi, respectively. (<bold>D</bold>) Numbers of splenic IgM/D<sup>hi</sup> and IgM/D<sup>lo</sup> CD273<sup>+</sup> and/or CD80<sup>+</sup> MSP1<sub>21</sub>-specific B<sub>mem</sub> in NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice during the course of mosquito transmitted <italic>P. chabaudi</italic> infection. Two-way ANOVA vs day 0. **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001. (<bold>E</bold>) Flow cytometry showing expression of CD38 on different subsets of splenic IgM/D<sup>hi</sup> and IgM/D<sup>lo</sup> MSP1<sub>21</sub>-specific B cells from NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice defined based on CD273 and CD80 expression at 155dpi. (<bold>F</bold>) Geometric MFI of CD38 expression on different subsets of IgM/D<sup>hi</sup> and IgM/D<sup>lo</sup> splenic MSP1<sub>21</sub>-specific B cells from NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice defined based on CD273 and CD80 expression at day 155 post-mosquito transmitted <italic>P. chabaudi</italic> infection. Two-way ANOVA vs CD273<sup>-</sup>CD80<sup>-</sup> subset. **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001. Error bars are SEM. (<bold>G</bold>) Flow cytometry of CD273 and CD80 expression on non-GC (CD38<sup>hi</sup>GL-7<sup>lo</sup>, blue) and GC (CD38<sup>lo</sup>GL-7<sup>hi</sup>, red) splenic MSP1<sub>21</sub>-specific B cells from NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice at 35dpi. (<bold>H</bold>) Flow cytometry of CD38 vs GL-7 (GC markers) on splenic MSP1<sub>21</sub>-specific B cells from NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice at 0 and 155dpi. (<bold>I</bold>) CD11b<sup>+</sup>CD11c<sup>+</sup> MSP1<sub>21</sub>-specific B cells overlaid on the CD80 vs CD273 plot corresponding to total MSP1<sub>21</sub>-specific B cells. Data pooled from three independent experiments with 3–7 mice per group.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-39800-fig5-v2"/></fig><p>These data show that, in contrast to the transient AMB, splenic CD80<sup>+</sup>CD273<sup>+</sup> and CD80<sup>+</sup>CD273<sup>—</sup> class-switched and non-class-switched MSP1<sub>21</sub>-specific B<sub>mem</sub> persist after resolution of <italic>P. chabaudi</italic> infection.</p></sec><sec id="s2-7"><title><italic>Plasmodium</italic>-specific B<sub>mem</sub> express high levels of FCRL5</title><p>As discussed above, no single marker has been described so far that can identify all mouse B<sub>mem</sub> subsets. Surprisingly, we observed that after resolution of infection (155-170dpi), MSP1<sub>21</sub>-specific B cells expressing different combinations of CD80 and CD273 (CD80<sup>+</sup>CD273<sup>+</sup>, CD80<sup>-</sup>CD273<sup>+</sup> or CD80<sup>+</sup>CD273<sup>-</sup>) all expressed very high levels of FCRL5, in contrast to CD80<sup>-</sup>CD273<sup>-</sup> MSP1<sub>21</sub>-specific B cells that express no memory markers at this stage (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). This suggests that FCRL5 might be a marker for all B<sub>mem</sub>. In order to confirm this, we used unsupervised methods to analyze our multiparameter flow cytometry data. We used PhenoGraph and t-SNE within the Cytofkit package (Materials and methods, Chen et al 2016) to analyze MSP1<sub>21</sub>-specific B cells based on the expression of FCRL5, CD38, IgD, CD80 and CD273 on these cells, as determined by flow cytometry (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>). The analysis identified six clusters of cells with memory characteristics displaying high expression of CD38, CD80 and/or CD273, and variable expression of IgD, all of which expressed high levels of FCRL5 (<xref ref-type="fig" rid="fig6">Figure 6C</xref>: clusters identified with purple arrows). We then used Isomap, (Cytofkit package) to infer the relatedness between those cell subsets identified by PhenoGraph. This confirmed high similarities between the cell clusters expressing high levels of FCRL5 with the clusters expressing high levels of the memory markers CD80, CD273 and CD38 (<xref ref-type="fig" rid="fig6">Figure 6D</xref>).</p><fig-group><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.39800.011</object-id><label>Figure 6.</label><caption><title>FCRL5<sup>hi</sup> identifies MSP1<sub>21</sub>-specific B<sub>mem</sub> after resolution of <italic>P.chabaudi</italic> infection.</title><p>(<bold>A</bold>) Flow cytometry showing expression of FCRL5 (right) on different subsets of splenic MSP1<sub>21</sub>-specific B cells from NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice defined based on CD273 and CD80 expression (left) at 155dpi. (<bold>B</bold>) t-SNE analysis of splenic MSP1<sub>21</sub>-specific B cells based on FCRL5, CD38, IgD, CD273 and CD80 expression measured by flow cytometry (n = 5). Clusters identified by PhenoGraph are colored and numbered. (<bold>C</bold>) PhenoGraph heat map showing median expression of FCRL5, CD38, IgD, CD273 and CD80 on the different clusters of MSP1<sub>21</sub>-specific B cells. Arrows point at the different clusters displaying a memory B cell phenotype. (<bold>D</bold>) Expression profiles of FCRL5, CD38, CD273 and CD80 for the different PhenoGraph clusters visualized on the first component of ISOMAP. The regression line estimated using the generalized linear model (GLM) is added for each marker. Data representative of three independent experiments with 4–7 mice per group. (<bold>E</bold>) Heat map showing expression levels of different genes on splenic FCRL5<sup>—</sup> and FCRL5<sup>hi</sup> MSP1<sub>21</sub>-specific B cells sorted at 155dpi, and MSP1<sub>21</sub>-specific B cells sorted before infection (naïve), determined by RNAseq analysis. Each column corresponds to data from an individual mouse (n = 5 155 dpi, n = 5 0 dpi).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-39800-fig6-v2"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.39800.012</object-id><label>Figure 6—figure supplement 1.</label><caption><title>Gating strategy for the sorting of splenic MSP1<sub>21</sub>-specific FCRL5<sup>hi</sup> B<sub>mem</sub> and FCRL5<sup>—</sup> B cells at 155dpi.</title></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-39800-fig6-figsupp1-v2"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.39800.013</object-id><label>Figure 6—figure supplement 2.</label><caption><title>High expression of FCRL5 identifies B<sub>mem</sub>.</title><p>(<bold>A</bold>) Flow cytometry gating strategy to identify splenic MSP1<sub>21</sub>-specific FCRL5<sup>neg</sup> (red) and FCRL5<sup>hi</sup> (blue) B cells, and additional surface markers expressed on these cells, in NIMP23→ <italic>Rag2<sup>-/-</sup></italic> mixed bone marrow chimeras infected with <italic>P. chabaudi</italic> (155dpi, top row) and immunized with recombinant MSP1<sub>21</sub> in Titermax Gold emulsion (day 29 post-immunization, bottom row). (<bold>B</bold>) Cumulative data showing geometric MFI for CD80, CD273, CD73, and CD38 memory markers on splenic MSP1<sub>21</sub>-specific FCRL5<sup>neg</sup> and FCRL5<sup>hi</sup> B cells obtained from immunized mice. Mann Whitney U test. **, p&lt;0.01. Error bars are SEM. Data representative of two independent experiments with 3–5 mice per group.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-39800-fig6-figsupp2-v2"/></fig></fig-group><p>To confirm the memory identity of MSP1<sub>21</sub>-specific FCRL5<sup>hi</sup> B-cells detected after resolution of the infection, we isolated MSP1<sub>21</sub>-specific B cells expressing either high levels of FCRL5 or not expressing FCRL5 (i.e. FCRL5<sup>hi</sup> and FCRL5<sup>—</sup> MSP1<sub>21</sub>-specific B cells) from the spleen of <italic>P. chabaudi</italic>-infected NIMP23→<italic>Rag2<sup>-/-</sup></italic> mice (155dpi) (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), and MSP1<sub>21</sub>-specific B cells from the spleen of naïve NIMP23→<italic>Rag2<sup>-/-</sup></italic> mice, by flow cytometric sorting, and performed mRNAseq analysis on these three sorted cell populations (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). As expected, the MSP1<sub>21</sub>-specific FCRL5<sup>hi</sup> B cell subset showed high expression of genes encoding the hallmark memory B cell markers <italic>Cd38</italic>, <italic>Cd80</italic>, <italic>Cd86</italic>, <italic>Nt5e</italic> (CD73) and <italic>Pdcd1lg2</italic> (CD273), when compared with either MSP1<sub>21</sub>-specific FCRL5<sup>—</sup> B cells sorted at the same time or MSP1<sub>21</sub>-specific B cells sorted from naïve mice (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). Moreover, the MSP1<sub>21</sub>-specific FCRL5<sup>hi</sup> B cells sorted after resolution of the infection upregulated the anti-apoptotic <italic>Bcl2</italic> gene, which is an additional hallmark characteristic of memory B cells (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). Importantly, FCRL5 also identified CD80<sup>+</sup> and CD273<sup>+</sup> MSP1<sub>21</sub>-specific B<sub>mem</sub> subsets generated following immunization with a model antigen (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>).</p><p>Thus, after resolution of the infection, high expression of FCRL5 identifies <italic>P. chabaudi</italic>-specific B<sub>mem</sub>.</p></sec><sec id="s2-8"><title><italic>Plasmodium</italic>-specific AMB are a distinct short-lived activated B cell subset</title><p>After identifying and sorting MSP1<sub>21</sub>-specific AMB during chronic <italic>P. chabaudi</italic> infection, and MSP1<sub>21</sub>-specific B<sub>mem</sub> after resolution of the infection, we then compared the transcriptome of these two B-cell subsets. Principal component analysis (PCA) demonstrated a strikingly distinct transcriptome of MSP1<sub>21</sub>-specific AMB from that of MSP1<sub>21</sub>-specific B<sub>mem</sub>, as well as all other MSP1<sub>21</sub>-specific B-cell subsets sorted in this study (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). The MSP1<sub>21</sub>-specific AMB sorted at 35dpi formed a separated cluster at the extreme right of the PC1 axis of the PCA plot, which accounts for the majority of the variance (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). All the other subsets [including MSP1<sub>21</sub>-specific CD11b<sup>—</sup>CD11c<sup>—</sup> B-cells sorted from the same mice and at the same day post-infection as the MSP1<sub>21</sub>-specific AMB (i.e. 35dpi)] clustered on the left of the PC1 axis, and showed differences mostly along the PC2 axis of the PCA plot, which accounts for only 10% of the variance (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Interestingly, MSP1<sub>21</sub>-specific CD11b<sup>—</sup>CD11c<sup>—</sup> and MSP1<sub>21</sub>-specific B<sub>mem</sub> clustered on opposite sides of the MSP1<sub>21</sub>-specific naïve B-cell subset along the PC2 axis (<xref ref-type="fig" rid="fig7">Figure 7A</xref>), which suggests that the MSP1<sub>21</sub>-specific B<sub>mem</sub> more closely resemble MSP1<sub>21</sub>-specific naïve B cells than MSP1<sub>21</sub>-specific CD11b<sup>—</sup>CD11c<sup>—</sup> B cells sorted at 35dpi.</p><fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.39800.014</object-id><label>Figure 7.</label><caption><title>MSP1<sub>21</sub>-specific AMB are a distinct short-lived activated B cell subset.</title><p>(<bold>A</bold>) Principal component analysis of RNAseq transcriptome data from splenic MSP1<sub>21</sub>-specific AMB (CD11b<sup>+</sup>CD11c<sup>+</sup>, 35dpi), CD11b<sup>—</sup>CD11c<sup>—</sup> B cells (35dpi), B<sub>mem</sub> (FCRL5<sup>hi</sup>, 155dpi), FCRL5<sup>—</sup> B cells (155dpi) and B cells from naïve mice (0dpi). The MSP1<sub>21</sub>-specific AMB and B<sub>mem</sub> are contained inside ellipses. (<bold>B</bold>) (<bold>C</bold>) (<bold>D</bold>) (<bold>E</bold>) Normalized counts corresponding to selected genes representing memory B-cell markers, anti and pro-apoptotic genes, immunoglobulins and atypical memory B-cell markers, respectively, for all five groups described in (<bold>A</bold>). Each bar represents an individual mouse. Data generated with five mice per group.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-39800-fig7-v2"/></fig><p>MSP1<sub>21</sub>-specific AMB sorted during chronic <italic>P. chabaudi</italic> infection, and MSP1<sub>21</sub>-specific B<sub>mem</sub> sorted after resolution of the infection shared the expression of a series of mouse memory markers, including <italic>Cd80</italic>, <italic>Fcrl5</italic>, <italic>Nt5e</italic> (CD73), and <italic>Cd86</italic> (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). However, these two subsets showed differences in the expression pattern of anti- and pro-apoptotic genes (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). While MSP1<sub>21</sub>-specific B<sub>mem</sub> from after infection resolution showed the highest levels of expression of the anti-apoptotic <italic>Bcl2</italic> gene, MSP1<sub>21</sub>-specific AMB sorted during chronic <italic>P. chabaudi</italic> infection showed the lowest levels of expression of this hallmark anti-apoptotic gene (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). In contrast to MSP1<sub>21</sub>-specific B<sub>mem</sub>, MSP1<sub>21</sub>-specific AMB expressed high levels of the pro-apoptotic genes <italic>Bad</italic>, <italic>Bax</italic>, <italic>Fas</italic> and <italic>Fasl</italic> (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). Interestingly, MSP1<sub>21</sub>-specific AMB expressed very high levels of class-switched immunoglobulins, including <italic>Igha</italic>, <italic>Ighg1</italic>, <italic>Ighg2b</italic>, <italic>Ighg2c</italic> and <italic>Ighg3</italic> (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). Finally, MSP1<sub>21</sub>-specific AMB highly expressed <italic>Cd11b</italic>, <italic>Cd11c</italic>, <italic>Tbx21</italic>, <italic>Ifng</italic> and <italic>Pdcd1</italic> (<xref ref-type="fig" rid="fig7">Figure 7E</xref>), all hallmarks of human AMB, as well as <italic>Mki67</italic>, indicative of active cell division, as previously shown in human AMB.</p><p>These data demonstrate that AMB and B<sub>mem</sub> share the expression of memory markers. However, they show striking differences in the expression of pro- and anti-apoptotic genes, immunoglobulins genes, and cell proliferation genes. The increased expression of <italic>Mki67</italic>, pro-apoptotic genes and class-switched immunoglobulins in AMB suggests that they resemble activated B cells. By contrast, B<sub>mem</sub> express much less <italic>Mki67</italic> (similar to naïve cells) and present an anti-apoptotic gene expression pattern, consistent with being long-lived quiescent B cells.</p><p>Mouse FCRL5 has been shown to be expressed on marginal zone (MZ) and B1 B cells (<xref ref-type="bibr" rid="bib75">Won et al., 2006</xref>). Therefore, it is possible that the AMB identified in this study might represent a specific subset of either MZ or B1 B cells. As discussed elsewhere (<xref ref-type="bibr" rid="bib6">Baumgarth, 2011</xref>; <xref ref-type="bibr" rid="bib23">Garraud et al., 2012</xref>; <xref ref-type="bibr" rid="bib51">Pillai et al., 2005</xref>; <xref ref-type="bibr" rid="bib78">Zouali, 2011</xref>), B1 and MZ B cells are CD1d<sup>mid/hi</sup>, CD9<sup>+</sup>, IgM<sup>hi</sup> and CD23<sup>—</sup>. B1 are further CD43<sup>+</sup>, B220<sup>lo</sup>, and may (B1a) or may not (B1b) express CD5. MZ are further characterised by CD22<sup>hi</sup>, CD21/CR2<sup>hi</sup>, and the expression of the lysophospholipid sphingosine-1 phosphate receptor S1P<sub>1</sub>, and the lineage master regulator Notch2. Indeed, MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> AMB showed high expression of some markers associated with B1 and/or MZ, including CD5, CD9 and CD43. However, these markers have also been shown to be highly expressed by activated B2 B cells and plasma cells (<xref ref-type="bibr" rid="bib6">Baumgarth, 2011</xref>). Studying all these canonical markers, we found no other similarities between B1/MZ and MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> AMB to suggest a relationship between these subsets (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). This was further corroborated by flow cytometry analysis (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). Moreover, unlike MZ and B1 B cells, MSP1<sub>21</sub>-specific AMB were class-switched and expressed very high levels of IgG (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). To further characterize the identity of MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> AMB, we explored if these cells resemble GC B cells. Flow cytometry analysis demonstrated that MSP1<sub>21</sub>-specific AMB did not display a GC phenotype (i.e. CD38<sup>hi</sup>GL-7<sup>lo</sup>) (<xref ref-type="fig" rid="fig8">Figure 8C</xref>) while the MSP1<sub>21</sub>-specific CD38<sup>lo</sup>GL-7<sup>hi</sup> GC B cells showed low expression of both CD11b and CD11c. Thus, MSP1<sub>21</sub>-specific AMB are not GC B cells.</p><fig id="fig8" position="float"><object-id pub-id-type="doi">10.7554/eLife.39800.015</object-id><label>Figure 8.</label><caption><title>Analysis of MZ, B1 and GC B cell characteristics on MSP1<sub>21</sub>-specific AMB.</title><p>(<bold>A</bold>) MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> (AMB) and CD11b<sup>—</sup>CD11c<sup>—</sup> B cells were flow cytometry sorted from the spleen of NIMP23→<italic>Rag2<sup>-/-</sup></italic> chimeric mice at 35dpi; MSP1<sub>21</sub>-specific B cells were flow cytometry sorted from the spleen of naïve NIMP23→<italic>Rag2<sup>-/-</sup></italic>, and these three B cell populations were submitted to mRNAseq analysis. The heat map displays level of expression of selected individual genes known to be up or downregulated on either MZ, B1 B cells or both. Each column represents an individual mouse. (<bold>B</bold>) Flow cytometry analysis of surface markers of either MZ, B1 B cells or both, on MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> (AMB) (blue) and MSP1<sub>21</sub>-specific IgM<sup>hi</sup> (red) B cells from the spleen of <italic>Igh</italic><sup>NIMP23/+</sup> mice at 20dpi. (<bold>C</bold>) Flow cytometry analysis of GC markers on MSP1<sub>21</sub>-specific CD11b<sup>—</sup>CD11c<sup>—</sup> (non-AMB, left) and CD11b<sup>+</sup>CD11c<sup>+</sup> (AMB, right) B cells from the spleen of <italic>Igh</italic><sup>NIMP23/+</sup> mice at 20dpi. (<bold>D</bold>) Flow cytometry analysis showing the expression of CD11b and CD11c on MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> (AMB, blue) compared to GC (CD38<sup>lo</sup>GL-7<sup>hi</sup>, red) B cells from the spleen of <italic>Igh</italic><sup>NIMP23/+</sup> mice. Data generated with 5–6 mice per group.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-39800-fig8-v2"/></fig><p>All together, these data further show that <italic>P. chabaudi</italic>-specific AMB represent a distinct subset of short-lived activated B cells.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Similar to other chronic infections [e.g. HIV, HCV and <italic>Mycobacterium tuberculosis</italic> (<xref ref-type="bibr" rid="bib31">Knox et al., 2017b</xref>; <xref ref-type="bibr" rid="bib54">Portugal et al., 2017</xref>)], <italic>Plasmodium</italic> infection, the cause of malaria, leads to an increase in the frequency of AMB [originally termed tissue-like memory B cells (<xref ref-type="bibr" rid="bib39">Moir et al., 2008</xref>)] in peripheral blood from <italic>P. falciparum</italic>-exposed subjects (<xref ref-type="bibr" rid="bib24">Illingworth et al., 2013</xref>; <xref ref-type="bibr" rid="bib53">Portugal et al., 2015</xref>; <xref ref-type="bibr" rid="bib66">Sullivan et al., 2016</xref>; <xref ref-type="bibr" rid="bib65">Sullivan et al., 2015</xref>; <xref ref-type="bibr" rid="bib73">Weiss et al., 2011</xref>; <xref ref-type="bibr" rid="bib72">Weiss et al., 2010</xref>; <xref ref-type="bibr" rid="bib71">Weiss et al., 2009</xref>). However, mouse models to investigate <italic>Plasmodium</italic>-specific AMB are lacking. Here we have generated an IgH knock-in transgenic mouse strain to study the generation of <italic>Plasmodium</italic>-specific AMB in a <italic>Plasmodium chabaudi</italic> infection. We demonstrate the generation of <italic>P. chabaudi</italic>-specific AMB in response to blood-stage mosquito-transmitted chronic <italic>P. chabaudi</italic> infection, and show the short-lived nature of these cells. <italic>P. chabaudi</italic> infections in mice present some outstanding characteristics for the study of AMB; a chronic phase which allows investigation of the impact of constant immune activation driven by persistent subpatent parasitemia, followed by a clearance phase which allows the study of immune responses after the infection is naturally resolved. Thus, it is possible to study both exhaustion driven by chronic immune activation, and memory immune responses which remain after <italic>P. chabaudi</italic> elimination.</p><p>The <italic>P. chabaudi</italic>-specific AMB we detected during the chronic phase of infection showed strong similarities to human AMB described in chronic malaria. These included being class-switched, and expressing mouse homologues of hallmark human atypical memory B-cell genes such as <italic>Itgax</italic> (Cd11b), <italic>Itgam</italic> (Cd11c), <italic>Cxcr3</italic>, <italic>Fcrl5</italic>, <italic>Tbx21</italic> (T-bet), <italic>Ifng</italic>, <italic>Cd80</italic>, <italic>Cd86</italic>, <italic>Aicda</italic>, and a series on inhibitory receptors, including <italic>Lair1</italic> and <italic>Pdcd1</italic> (PD-1). Human AMB have been shown to share several characteristics with plasmablasts (<xref ref-type="bibr" rid="bib30">Knox et al., 2017a</xref>; <xref ref-type="bibr" rid="bib40">Muellenbeck et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">Obeng-Adjei et al., 2017</xref>; <xref ref-type="bibr" rid="bib65">Sullivan et al., 2015</xref>). Interestingly, we also observed increased expression of several genes associated with plasmablasts in <italic>P. chabaudi</italic>-specific AMB, including <italic>Cd138</italic>, <italic>Xbp1</italic>, <italic>Prdm1</italic> (encoding Blimp-1) and <italic>Mki67</italic>, accompanied by downregulation of <italic>Pax5</italic> and <italic>Bcl6</italic>.</p><p>AMB resemble age-associated B cells (ABC) which accumulate with age as well as in autoimmunity, and were also proposed to be a subset of long-lived memory B cells (<xref ref-type="bibr" rid="bib41">Naradikian et al., 2016a</xref>; <xref ref-type="bibr" rid="bib54">Portugal et al., 2017</xref>; <xref ref-type="bibr" rid="bib58">Rubtsov et al., 2017</xref>). Expression of T-bet, CD11c and CXCR3 are shared by AMB, tissue-like memory B cells, and ABC (<xref ref-type="bibr" rid="bib31">Knox et al., 2017b</xref>; <xref ref-type="bibr" rid="bib41">Naradikian et al., 2016a</xref>). Moreover, similar to ABC, expansion of human AMB associated with malaria is driven by IFNγ (<xref ref-type="bibr" rid="bib48">Obeng-Adjei et al., 2017</xref>). IL-21, which is highly expressed by follicular helper T cells in response to <italic>Plasmodium</italic> infection (<xref ref-type="bibr" rid="bib10">Carpio et al., 2015</xref>; <xref ref-type="bibr" rid="bib47">Obeng-Adjei et al., 2015</xref>; <xref ref-type="bibr" rid="bib49">Pérez-Mazliah et al., 2015</xref>), also directly promotes T-bet expression in B cells in the context of TLR engagement (<xref ref-type="bibr" rid="bib42">Naradikian et al., 2016b</xref>). Taken together, these data strongly suggest that this is the same T-bet<sup>+</sup> B-cell subset, which accumulates with time due to repetitive antigenic exposure. In agreement with previous data (<xref ref-type="bibr" rid="bib59">Rubtsova et al., 2013</xref>), we show here that immunization with MSP1<sub>21</sub> and R848, a TLR7/8 ligand, promotes a robust but short-lived CD11b<sup>+</sup>CD11c<sup>+</sup> <italic>P. chabaudi</italic>-specific AMB response. T-bet<sup>+</sup> atypical B cells are critical to eradicate various murine viral infections (<xref ref-type="bibr" rid="bib4">Barnett et al., 2016</xref>; <xref ref-type="bibr" rid="bib59">Rubtsova et al., 2013</xref>), and a recent study showed that yellow fever and vaccinia vaccinations of humans stimulated an acute T-bet<sup>+</sup> B-cell response and suggested that these T-bet<sup>+</sup> B-cell population may function as an early responder during acute viral infections (<xref ref-type="bibr" rid="bib30">Knox et al., 2017a</xref>). Thus, T-bet<sup>+</sup> B cells, even in the context of malaria, are likely to be a normal component of the immune compartment that becomes activated and expands, most probably in response to BCR, endosomal TLR, and IFNγ or IL-21 stimulation. Moreover, a recent study shows a TLR9/IFNγ-dependent activation of autoreactive T-bet<sup>+</sup>CD11c<sup>+</sup> atypical B cells in response to <italic>P. yoelii</italic> 17XNL infection in mice (<xref ref-type="bibr" rid="bib57">Rivera-Correa et al., 2017</xref>). However, whether these cells remained part of the long-lived memory B-cell pool after resolution of the infection was not explored.</p><p>Here, we show that <italic>P. chabaudi</italic>-specific AMB are short-lived activated B cells. These cells were absent after resolution of the infection, and immunization with purified antigen and TLR agonists resulted in a transient, yet robust, activation of <italic>P. chabaudi</italic>-specific AMB which lasted no more than 48 hr. Moreover, the <italic>Igh</italic><sup>NIMP23/+</sup> mouse model allowed us to obtain a deep insight of the transcriptome profile of MSP1<sub>21</sub>-specific AMB during natural infection, and compare it side-by-side with the transcriptome of MSP1<sub>21</sub>-specific naïve B cells. This allowed us to demonstrate their heavily pro-apoptotic and activated transcription profile, further explaining their short-lived nature. <italic>P. chabaudi</italic>-specific AMB showed very low expression of <italic>Bcl2</italic>, and high levels of expression of several pro-apoptotic genes including <italic>Bad</italic>, <italic>Bax</italic>, <italic>Fas</italic> and <italic>Fasl.</italic> In addition, these cells expressed very high levels of class-switched immunoglobulins and genes associated with DNA replication and proliferation.</p><p>The association of <italic>P. chabaudi</italic>-specific AMB with ongoing infection explains several observations in human studies: reduction of HIV plasma viremia by ART resulted in a significant reduction of HIV-specific AMB without altering the frequency of HIV-specific B<sub>mem</sub> (<xref ref-type="bibr" rid="bib16">de Bree et al., 2017</xref>; <xref ref-type="bibr" rid="bib29">Kardava et al., 2014</xref>); individuals living in high malaria endemicity present higher frequencies of AMB than individuals living in areas with moderate transmission (<xref ref-type="bibr" rid="bib24">Illingworth et al., 2013</xref>; <xref ref-type="bibr" rid="bib65">Sullivan et al., 2015</xref>); repetitive <italic>Plasmodium</italic> episodes result in higher frequencies of AMB (<xref ref-type="bibr" rid="bib48">Obeng-Adjei et al., 2017</xref>); the percentage of AMB is larger in children with persistent asymptomatic <italic>Plasmodium falciparum</italic> parasitemia as compared with parasite-free children (<xref ref-type="bibr" rid="bib71">Weiss et al., 2009</xref>); previously exposed subjects significantly reduce the frequency of AMB following a year of continuous absence of exposure to <italic>Plasmodium falciparum</italic> infection (<xref ref-type="bibr" rid="bib3">Ayieko et al., 2013</xref>). These observations all support the view that constant immune activation rather than impaired memory function leads to the accumulation of AMB in malaria.</p><p>After resolution of infection, <italic>P. chabaudi</italic>-specific AMB did not persist, but instead subsets of <italic>P. chabaudi</italic>-specific B<sub>mem</sub> were readily detected. These cells expressed different combinations of previously described mouse B-cell memory markers [i.e. CD80, CD273 and CD73 (<xref ref-type="bibr" rid="bib2">Anderson et al., 2007</xref>; <xref ref-type="bibr" rid="bib69">Tomayko et al., 2010</xref>; <xref ref-type="bibr" rid="bib79">Zuccarino-Catania et al., 2014</xref>)]. <italic>P. chabaudi</italic>-specific B<sub>mem</sub> included both class-switched and non-class-switched cells, which show different responses to a secondary challenge infection (<xref ref-type="bibr" rid="bib32">Krishnamurty et al., 2016</xref>). Independently of the combination of previously described memory markers expressed on <italic>P. chabaudi</italic>-specific B<sub>mem</sub>, all of these cells displayed very high expression of FCRL5. Previous data showed most prominent expression of FCRL5 in marginal zone B cells, while much less evident in the newly-formed and follicular splenic B cell subpopulations (<xref ref-type="bibr" rid="bib14">Davis et al., 2004</xref>; <xref ref-type="bibr" rid="bib75">Won et al., 2006</xref>). In agreement with this, we observed expression of FCRL5 on a subset of splenic <italic>P. chabaudi</italic>-specific B cells obtained from naïve mice. However, the level of FCRL5 expression on <italic>P. chabaudi</italic>-specific B<sub>mem</sub> detected after resolution of the infection was noticeably higher than that of naïve B cells both at the protein and mRNA levels. In contrast to MSP1<sub>21</sub>-specific AMB, these CD11b<sup>—</sup>CD11c<sup>—</sup>FCRL5<sup>hi</sup> MSP1<sub>21</sub>-specific B<sub>mem</sub> showed high expression of the hallmark memory and anti-apoptotic gene <italic>Bcl2</italic> (<xref ref-type="bibr" rid="bib7">Bhattacharya et al., 2007</xref>). Thus, after resolution of the infection, high expression of FCRL5 acted as a universal B<sub>mem</sub> marker. Due to its complex dual ITIM/ITAM signaling capacity (<xref ref-type="bibr" rid="bib77">Zhu et al., 2013</xref>), it is tempting to speculate that FCRL5 might serve as an important signal in the differentiation/maintenance of B<sub>mem</sub>.</p><p>Tracking the fate of the different MSP1<sub>21</sub>-specific B-cell subsets identified in this work will allow detailing the interplay between them. A model can be proposed in which antigen-specific AMB serve as an intermediate stage of differentiation between naïve and B<sub>mem</sub>. Alternatively, antigen-specific AMB might represent early plasmablasts or recent GC emigrates, based on class-switching and the high expression of IgG by these cells. These scenarios are not necessarily antagonist, and might even occur in parallel. Moreover, B1 B cells have been shown to class-switch and contribute to serum IgG1, IgG2a and IgA to influenza (<xref ref-type="bibr" rid="bib5">Baumgarth et al., 2005</xref>), and IgG-producing B1a B cells have been shown to accumulate in the spleen of a mouse model of systemic lupus erythematosus (<xref ref-type="bibr" rid="bib21">Enghard et al., 2010</xref>). Therefore, we can’t rule out the possibility that AMB might represent a particular B1 B cell subset that expands in the spleen and blood in response to <italic>Plasmodium</italic> infection.</p><p>Our data suggest that the expansion of AMB in malaria is not a consequence of B-cell exhaustion, but rather a physiologic stage of B-cell activation, and that these cells are sustained in high frequencies by ongoing chronic infections. Thus, <italic>Plasmodium</italic>-specific AMB are neither ‘memory’, nor ‘atypical’. Importantly, our data demonstrate that robust expansion of <italic>Plasmodium</italic>-specific AMB does not hinder clearance of the infection, activation of germinal centers, or generation of <italic>Plasmodium</italic>-specific long-lived quiescent B<sub>mem</sub> upon resolution of the infection.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent <break/>type (species) <break/>or resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Genetic <break/>reagent <break/>(<italic>M. musculus</italic>)</td><td>B6.SJL-Ptprc<sup>a</sup> Pepc<sup>b</sup>/BoyJ <break/>(B6.CD45.1)</td><td>The Jackson <break/>Laboratory</td><td>MGI:4819849</td><td>Bred in the specific <break/>pathogen-free <break/>facilities of the MRC <break/>National Institute <break/>for Medical Research <break/>and The Francis Crick <break/>Institute</td></tr><tr><td>Genetic reagent <break/>(<italic>M. musculus</italic>)</td><td>Rag2<sup>tm1Fwa</sup>(<italic>Rag2</italic><sup>-/-</sup>)</td><td>The Jackson <break/>Laboratory</td><td>MGI:1858556</td><td>Bred in the <break/>specific pathogen- <break/>free facilities of the <break/>MRC National Institute <break/>for Medical Research <break/>and The Francis Crick <break/>Institute</td></tr><tr><td>Genetic reagent <break/>(<italic>M. musculus</italic>)</td><td><italic>Igh</italic><sup>NIMP23/+</sup></td><td>This paper</td><td>_</td><td>Bred in the specific <break/>pathogen-free facilities <break/>of the MRC National <break/>Institute for Medical <break/>Research and The Francis <break/>Crick Institute</td></tr><tr><td>Strain, <break/>strain background (<italic>Plasmodium</italic> <break/><italic>chabaudi</italic> <break/><italic>chabaudi</italic>, <break/><break/>strain AS)</td><td><italic>P. chabaudi</italic></td><td>other</td><td>_</td><td>European Malaria <break/>Reagent Repository, <break/>University of Edinburgh.</td></tr><tr><td>Strain, <break/>strain <break/>background <break/>(<italic>Anopheles</italic> <break/><italic>stephensi</italic>, <break/>strain <break/>SD500, <break/>female)</td><td>mosquitos</td><td>PMID: 23217144</td><td>_</td><td>Bred in Jean <break/>Langhorne's lab</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat Anti-CD11b</td><td>BD Biosciences</td><td>563553</td><td>(dil 1/50)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Hamster <break/>Anti-Mouse <break/>CD11c</td><td>BD Biosciences</td><td>561022</td><td>(dil 1/50)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat Anti-Mouse <break/>CD138</td><td>BD Biosciences</td><td>553714</td><td>(dil 1/400)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat Anti-Mouse <break/>CD19</td><td>BD Biosciences</td><td>565076</td><td>(dil 1/200)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat anti-Mouse <break/>CD19</td><td>Biolegend</td><td>115530</td><td>(dil 1/400)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat anti-Mouse <break/>CD19 <break/></td><td>Biolegend</td><td>115543</td><td>(dil 1/400)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat anti-Mouse <break/>CD1d</td><td>Biolegend</td><td>123510</td><td>(dil 1/100)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat anti-mouse <break/>CD2</td><td>Biolegend</td><td>100112</td><td>(dil 1/100)</td></tr><tr><td>Antibody</td><td>Monoclona <break/>Rat <break/>Anti-Mouse <break/>CD21/35</td><td>BD Biosciences</td><td>563176</td><td>(dil 1/100)</td></tr><tr><td>Antibody</td><td>Monoclona Rat <break/>Anti-Mouse <break/>CD21/35</td><td>BD Biosciences</td><td>553818</td><td>(dil 1/100)</td></tr><tr><td>Antibody</td><td>Monoclonal Rat <break/>anti-Mouse <break/>CD23</td><td>eBioscience</td><td>25–0232</td><td>(dil 1/100)</td></tr><tr><td>Antibody</td><td>Monoclonal Rat <break/>anti-Mouse <break/>CD273</td><td>BD Biosciences</td><td>564245</td><td>(dil 1/25)</td></tr><tr><td>Antibody</td><td>Armenian <break/>Hamster <break/>anti-Mouse <break/>CD3</td><td>Biolegend</td><td>100336</td><td>(dil 1/100)</td></tr><tr><td>Antibody</td><td>Monoclonal Rat <break/>anti-Mouse <break/>CD38</td><td>Biolegend</td><td>102718</td><td>(dil 1/400)</td></tr><tr><td>Antibody</td><td>Monoclonal Rat <break/>anti-Mouse <break/>CD38</td><td>eBioscience</td><td>17–0381</td><td>(dil 1/400)</td></tr><tr><td>Antibody</td><td>Monoclonal Rat <break/>anti-Mouse <break/>CD38</td><td>BD Biosciences</td><td>740697</td><td>(dil 1/400)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat anti-Mouse <break/>CD4</td><td>Biolegend</td><td>100414</td><td>(dil 1/400)</td></tr><tr><td>Antibody</td><td>Monoclonal Rat <break/>anti-Mouse <break/>CD45.1</td><td>Biolegend</td><td>110706</td><td>(dil 1/400)</td></tr><tr><td>Antibody</td><td>Monoclonal Rat <break/>anti-Mouse <break/>CD45.1</td><td>Biolegend</td><td>110728</td><td>(dil 1/400)</td></tr><tr><td>Antibody</td><td>Monoclonal Mouse <break/>anti-Mouse <break/>CD45.2</td><td>BD Biosciences</td><td>563685</td><td>(dil 1/50)</td></tr><tr><td>Antibody</td><td>Monoclonal Mouse <break/>anti-Mouse <break/>CD45.2</td><td>Biolegend</td><td>109814</td><td>(dil 1/50)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Mouse <break/>anti-Mouse <break/>CD45.2</td><td>Biolegend</td><td>109808</td><td>(dil 1/50)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat <break/>anti-Mouse CD45R/B220</td><td>BD Biosciences</td><td>564449</td><td>(dil 1/400)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat <break/>anti-Mouse CD45R/B220</td><td>Biolegend</td><td>103224</td><td>(dil 1/400)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat <break/>anti-Mouse CD45R/B220</td><td>eBioscience</td><td>25–0452</td><td>(dil 1/400)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat anti-Mouse <break/>CD73</td><td>BD Biosciences</td><td>550741</td><td>(dil 1/100)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Armenian <break/>Hamster <break/>anti-Mouse CD80</td><td>Biolegend</td><td>104729</td><td>(dil 1/25)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat anti-Mouse <break/>CD8a</td><td>Biolegend</td><td>100734</td><td>(dil 1/400)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat anti-Mouse <break/>CD9</td><td>BD Biosciences</td><td>558749</td><td>(dil 1/100)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat anti-Mouse <break/>CD93 (AA4.1)</td><td>eBioscience</td><td>17–5892</td><td>(dil 1/100)</td></tr><tr><td>Antibody</td><td>FCRL5</td><td>PMID: 17082595</td><td>_</td><td>Produced in Randall Davis' lab (dil 1/400)</td></tr><tr><td>Antibody</td><td>Polyclonal <break/>Sheep <break/>anti-Mouse FCRL5</td><td>R and D Systems</td><td>FAB6756G</td><td>(dil 1/50)</td></tr><tr><td>Antibody</td><td>Monoclonal Rat <break/>Anti-Mouse <break/>T- and B-Cell <break/>Activation Antigen <break/>GL7</td><td>BD Biosciences</td><td>562080</td><td>(dil 1/100)</td></tr><tr><td>Antibody</td><td>Monoclonal Rat <break/>Anti-Mouse <break/>IgD</td><td>Biolegend</td><td>405725</td><td>(dil 1/400)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat Anti-Mouse <break/>IgD</td><td>Biolegend</td><td>405723</td><td>(dil 1/400)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat Anti-Mouse <break/>IgD</td><td>Biolegend</td><td>405710</td><td>(dil 1/400)</td></tr><tr><td>Antibody</td><td>Monoclonal Rat <break/>Anti-Mouse <break/>IgG2b</td><td>Biolegend</td><td>406708</td><td>(dil 1/25)</td></tr><tr><td>Antibody</td><td>Monoclonal <break/>Rat Anti-Mouse <break/>IgM</td><td>Biolegend</td><td>406512</td><td>(dil 1/100)</td></tr><tr><td>Recombinant DNA reagent</td><td>VDJ<sub>H</sub><sup>NIMP23</sup> <break/>anti-MSP1<sub>21</sub> <break/>variable region <break/>coding exon <break/>containing the <break/>Leader-V <break/>segment intron <break/>from gDNA of the <break/>NIMP23 hybridoma</td><td>PMID: 7141700</td><td>_</td><td>Produced in Jean Langhorne's lab</td></tr><tr><td>Recombinant DNA reagent</td><td>C57Bl/6 IgH <break/>HEL variable <break/>region <break/>knock-in <break/>construct</td><td>PMID: 12668643</td><td>_</td><td>Donated by Robert <break/>Brink of the Garvan Institute <break/>of Medical Research, New South Wales, Australia</td></tr><tr><td>Peptide, recombinant protein</td><td valign="bottom">MSP1<sub>21</sub></td><td>PMID: 11254580</td><td>_</td><td>Produced in Jean Langhorne's lab</td></tr><tr><td>Commercial assay or kit</td><td>EZ-Link <break/>Sulfo-NHS-LC-Biotinylation <break/>Kit</td><td>Thermo Scientific</td><td>21435</td><td/></tr><tr><td>Commercial assay or kit</td><td>RiboPure <break/>RNA Purification <break/>Kit <break/></td><td>Invitrogen</td><td>AM1924</td><td/></tr><tr><td>Commercial assay or kit</td><td>Qubit 1X <break/>dsDNA HS <break/>Assay Kit</td><td>Invitrogen</td><td>Q33231</td><td/></tr><tr><td>Commercial assay or kit</td><td>SMART-Seq <break/>v4 Ultra Low <break/>Input RNA <break/>Kit for Sequencing</td><td>Takara</td><td>634889</td><td/></tr><tr><td>Commercial assay or kit</td><td>Ovation <break/>Ultralow Library <break/>System V2</td><td>Nugen</td><td>0344–32</td><td/></tr><tr><td>Commercial assay or kit</td><td>LIVE/DEAD <break/>Fixable Aqua <break/>Dead Cell Stain Kit</td><td>Invitrogen</td><td>L34957</td><td/></tr><tr><td>Commercial assay or kit</td><td>LIVE/DEAD <break/>Fixable Blue <break/>Dead Cell Stain Kit</td><td>Invitrogen</td><td>L23105</td><td/></tr><tr><td>Chemical compound, drug</td><td>Streptavidin-R-Phycoerythrin</td><td>Prozyme</td><td>PJRS25</td><td/></tr><tr><td>Chemical compound, drug</td><td>Streptavidin-Allophycocyanin</td><td>Prozyme</td><td>PJ27S</td><td/></tr><tr><td>Chemical compound, drug</td><td>TiterMax <break/>Gold Adjuvant</td><td>Merck (formerly Sigma-Aldrich)</td><td>T2684-1ML</td><td/></tr><tr><td>Chemical compound, drug</td><td>R848 (Resiquimod)</td><td>Invivogen</td><td>tlrl-r848</td><td/></tr><tr><td>Chemical compound, drug</td><td>TRI Reagent <break/>Solution</td><td>Invitrogen</td><td>AM9738</td><td/></tr><tr><td>Software, algorithm</td><td>cutadapt v1.9.1</td><td>doi:10.14806/ej.17.1.200</td><td/><td/></tr><tr><td>Software, algorithm</td><td>RSEM v1.2.31</td><td>doi:10.1186/1471-2105-12-323</td><td/><td/></tr><tr><td>Software, algorithm</td><td>STAR v2.5.1b</td><td>doi:10.1093/ <break/>bioinformatics/bts635</td><td/><td/></tr><tr><td>Software, algorithm</td><td>DESeq2</td><td>doi:10.1186/s13059-014-0550-8</td><td/><td/></tr><tr><td>Software, algorithm</td><td>R v3.4.0</td><td>other</td><td/><td><ext-link ext-link-type="uri" xlink:href="https://www.r-project.org"><underline>https://www.r-project.org</underline></ext-link></td></tr><tr><td>Software, algorithm</td><td>Bioconductor <break/>v3.5</td><td>other</td><td/><td><ext-link ext-link-type="uri" xlink:href="http://www.bioconductor.org">http://www.</ext-link> <break/><ext-link ext-link-type="uri" xlink:href="http://www.bioconductor.org">bioconductor.org</ext-link></td></tr><tr><td>Software, algorithm</td><td>Broad's <break/>Gene Set <break/>Enrichment <break/>Analysis (GSEA)</td><td>other</td><td/><td><ext-link ext-link-type="uri" xlink:href="http://software.broadinstitute.org/gsea/index.jsp">http://software.broadinstitute.org/gsea/index.jsp</ext-link></td></tr><tr><td>Software, algorithm</td><td>FlowJo version 9.6 or higher</td><td>Tree Star</td><td/><td/></tr><tr><td>Software, algorithm</td><td>Cytofkit</td><td>doi:10.1371/journa <break/>l.pcbi.1005112.s009</td><td/><td/></tr><tr><td>Software, algorithm</td><td>Prism v6</td><td>GraphPad</td><td/><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>5-12 week-old female mice were used for experiments. C57BL/6J, C57BL/6.SJL-<italic>Ptprc<sup>a</sup></italic> (CD45.1 congenic), <italic>Rag2<sup>-/-</sup></italic>.C57BL/6.SJL-<italic>Ptprc<sup>a</sup></italic> (CD45.1 congenic) and BALB/c mouse strains were bred in the specific pathogen-free facilities of the MRC National Institute for Medical Research and The Francis Crick Institute, and were housed conventionally with sterile bedding, food and irradiated water. Room temperature was 22°C with a 12 hr light/dark cycle; food and water were provided ad libitum. The study was carried out in accordance with the UK Animals (Scientific Procedures) Act 1986 (Home Office license 80/2538 and 70/8326), was approved by the MRC National Institute for Medical Research Ethical Committee and was approved by The Francis Crick Institute Ethical Committee.</p><p>To produce MSP1<sub>21</sub>–specific B cell knock-in mice capable of undergoing class switch recombination on the C57BL/6J genetic background, the VDJ<sub>H</sub><sup>NIMP23</sup> anti-MSP1<sub>21</sub> variable region coding exon containing the Leader-V segment intron from gDNA of the NIMP23 hybridoma (<xref ref-type="bibr" rid="bib8">Boyle et al., 1982</xref>) was inserted by homologous recombination into the 5’ end of the endogenous IgH locus (<xref ref-type="bibr" rid="bib67">Taki et al., 1993</xref>) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–C</xref>). The VDJ<sub>H</sub><sup>NIMP23</sup> anti-MSP1<sub>21</sub> variable region coding exon was inserted into a previously described IgH targeting construct, replacing the anti-HEL heavy chain variable region coding exon that was already in it (<xref ref-type="bibr" rid="bib50">Phan et al., 2003</xref>) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). The final targeting construct included a loxP-flanked neomycin resistance cassette in reverse transcriptional orientation to the <italic>Igh</italic> locus, located immediately 5’ to the rearranged VDJ<sub>H</sub><sup>NIMP23</sup> variable region and its associated promoter (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). Electroporation of C57BL/6N-derived PRX embryonic stem cells with the targeting construct and selection of homologous recombinant clones was performed using standard techniques by PolyGene AG (Switzerland). One targeted ES clone was used for production of chimeric mice using standard techniques at the Biological Research Facilities of the MRC National Institute for Medical Research, London, UK. Male chimeric mice were crossed to C57BL/6J females and progeny carrying the <italic>Igh</italic><sup>NIMP23neo</sup> allele were crossed to PC3Cre mice (<xref ref-type="bibr" rid="bib46">O'Gorman et al., 1997</xref>) to delete the neo<sup>r</sup> gene in the germline and generate mice carrying the <italic>Igh</italic><sup>NIMP23</sup> allele (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). The <italic>Igh</italic><sup>NIMP23/+</sup> strain was maintained by backcrossing for at least 10 generations to C57BL/6J mice.</p></sec><sec id="s4-2"><title>Mixed bone marrow chimeras</title><p>Femurs and tibias were excised from female mice and cleaned of flesh using forceps and scalpel, and BM was obtained by flushing out with IMDM supplemented with 2 mM L-glutamine, 0.5 mM sodium pyruvate, 100 U penicillin, 100 mg streptomycin, 6 mM Hepes buffer, and 50 mM 2-ME (Gibco, Invitrogen), using a syringe with a needle. Thereafter, single BM cell suspensions were obtained by mashing through a 70 μm filter mesh, further sieved through 40 μm filter mesh and washed once. Live cells were resuspended in sodium chloride solution 0.9% (Sigma) at 4 × 10<sup>6</sup> cells/200 μl. <italic>Rag2<sup>-/-</sup></italic>.C57BL/6.SJL-<italic>Ptprc<sup>a</sup></italic> mice were sub-lethally irradiated (5Gy) using a [137Cs] source and reconstituted less than 24 hr after irradiation by i.v. injections of a 10% <italic>Igh</italic><sup>NIMP23/+</sup>:90% C57BL/6.SJL-<italic>Ptprc<sup>a</sup></italic> combination of donor BM cells. Recipient mice were maintained on acidified drinking water and analyzed for reconstitution after 6–8 weeks.</p></sec><sec id="s4-3"><title><italic>Plasmodium chabaudi</italic> infection</title><p><italic>Plasmodium chabaudi chabaudi AS</italic> was transmitted by <italic>Anopheles stephensi</italic> mosquitoes, strain SD500, as described elsewhere (<xref ref-type="bibr" rid="bib62">Spence et al., 2012</xref>). Briefly, C57BL/6J mice were injected i.p. with 10<sup>5</sup> <italic>P. chabaudi</italic>-infected red blood cells and used to feed mosquitos two weeks after the injection. Two weeks after mosquito feeding/infection, each experimental mouse was exposed to 20 infected mosquitos for 30 min. Blood parasitemia in infected experimental mice was routinely monitored by thin blood smears.</p></sec><sec id="s4-4"><title>Immunizations</title><p>Mice were immunized i.p. with a combination of 100 μg of MSP1<sub>21</sub> (<xref ref-type="bibr" rid="bib55">Quin and Langhorne, 2001</xref>) and 50 μl of Titermax Gold emulsion (Sigma), or a combination of 50 μg of MSP1<sub>21</sub> and 50 μg of R848 (Invivogen).</p></sec><sec id="s4-5"><title>Flow cytometry and cell sorting</title><p>Spleens, lymph nodes and bone marrows were dissected and single cell suspensions were obtained by mashing the organs through a 70 μm filter mesh in HBSS, 6 mM Hepes buffer (Gibco, Invitrogen). After removal of red blood cells from spleens and bone marrows by treatment with lysing buffer (Sigma), the remaining cells were resuspended in complete Iscove's Modified Dulbecco's Medium [IMDM supplemented with 10% FBS Serum Gold (PAA Laboratories, GE Healthcare), 2 mM L-glutamine, 0.5 mM sodium pyruvate, 100U penicillin, 100 mg streptomycin, 6 mM Hepes buffer, and 50 mM 2-ME (all from Gibco, Invitrogen)] and viable cells were counted using trypan blue (Sigma) exclusion and a hemocytometer. Cells were then resuspended in PBS and incubated with APC- or PE-labelled MSP1<sub>21</sub> fluorescent probes and/or different combinations of fluorochrome-conjugated antibodies (key resources table), and either acquired after two washes with PBS, or fixed with 2% paraformaldehyde and stored in staining buffer at 4°C until acquisition.</p><p>The APC and PE MSP1<sub>21</sub> fluorescent probes were produced as previously described (<xref ref-type="bibr" rid="bib32">Krishnamurty et al., 2016</xref>; <xref ref-type="bibr" rid="bib68">Taylor et al., 2012</xref>). Briefly, purified MSP1<sub>21</sub> (<xref ref-type="bibr" rid="bib55">Quin and Langhorne, 2001</xref>) was biotinylated using an EZ-link Sulfo-NHS-LC- Biotinylation kit (Thermo Fisher Scientic) using a 1:1 ratio of biotin to protein, and loaded onto Streptavidin-APC conjugated or Phycolink Streptavidin-R-PE conjugated (ProZyme) in a 6:1 ratio of MSP1<sub>21</sub>:Streptavidin-fluorochrome.</p><p>Cell sorting was performed on a MoFlo XDP (Beckman Coulter) or a BD FACSAria Fusion (BD Biosciences) and the target cell populations were directly dispensed into TRIreagent (Ambion) and stored at −80°C until RNA isolation. Purity checks were routinely performed for all assays by sorting aliquots of cells into PBS containing 2% FCS and reacquiring them on the cell sorter.</p><p>Dead cells were routinely excluded from the analysis by staining with LIVE/DEAD Fixable Aqua or Blue stain (Invitrogen). Singlets were selected based on FCS-A vs FCS-H and further based on SSC-A vs SSC-H. ‘Fluorescence minus one’ (FMO) controls were routinely used to verify correct compensation and to set the thresholds for positive/negative events. Analysis was performed with FlowJo software version 9.6 or higher (Tree Star).</p><p>PhenoGraph and <italic>t</italic>-distributed stochastic neighbor embedding (t-SNE) were combined to analyze multiparameter flow cytometry data using the Cytofkit package (<xref ref-type="bibr" rid="bib12">Chen et al., 2016</xref>). t-SNE renders high-dimensional single-cell data based on similarities into only two dimensions, and thus helps visualize multiparameter data (<xref ref-type="bibr" rid="bib70">van der Maaten, 2008</xref>). PhenoGraph (<xref ref-type="bibr" rid="bib34">Levine et al., 2015</xref>) allows partitioning of high-dimensional single-cell data into phenotypically coherent subpopulations (i.e. clusters). The relatedness of the cell clusters identified by PhenoGraph was inferred using Isomap (Cytofkit package), in which related clusters/subsets can be visualised close to each other.</p></sec><sec id="s4-6"><title>RNA isolation, sequencing and data analysis</title><p>Total RNA from 1−5 × 10<sup>4</sup> cells sorted into TRIreagent (Ambion) was isolated using the Ribopure kit (Ambion). Concentration of purified RNA was determined by Qubit fluorometric quantitation using the HS assay kit (ThermoFisher Scientific), and the quality analyzed with a 2100 Bioanalyzer (Agilent). Samples with a RIN score above 8.50 were used for the next steps. cDNA was generated from total RNA with the SMART-Seq v4 Ultra Low Input RNA Kit (Takara Bio USA). Next-generation sequencing libraries were produced with the Ovation Ultralow System V2 (Nugen), and run as PE100 on a HiSeq 4000 sequencer (Illumina). GEO accession: GSE115155.</p><p>For bioinformatics analysis, paired-end sequence reads were adapter and quality trimmed using cutadapt v1.9.1 (<xref ref-type="bibr" rid="bib38">Martin, 2011</xref>) with the following non-default settings: ‘-a AGATCGGAAGAGC -A AGATCGGAAGAGC --minimum-length 30 -q 20,20’. Gene-level abundance estimates were generated from the trimmed reads using RSEM v1.2.31 (<xref ref-type="bibr" rid="bib35">Li and Dewey, 2011</xref>) running STAR v2.5.1b (<xref ref-type="bibr" rid="bib17">Dobin et al., 2013</xref>) with default settings, aligned against the <italic>Mus musculus</italic> Ensembl release 89 transcriptome (mm10). All further analysis was conducted using the DESeq2 (<xref ref-type="bibr" rid="bib37">Love et al., 2014</xref>) package from Bioconductor v3.5 run in R v3.4.0. The expected counts were imported and rounded to integers to generate a counts matrix. Differential expression between phenotype groups was assessed using the DESeq function with default settings. In the case of comparisons of different MSP1<sub>21</sub>-specific B cell subsets obtained from the same experimental mouse, an additional mouse factor was added to the design formula to accommodate the paired nature of the data. Significance was thresholded using an FDR ≤ 0.01. PCA analysis was conducted using DESeq's plot PCA function with the regularized log (rlog) transformed count data. Heat maps were generated using the regularized log (rlog) transformed count data, scaled per gene using a z-score. Mouse homologues to genes previously associated with human AMB were selected (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), and those showing significant differential expression on MSP1<sub>21</sub>-specific AMB were used to produce separate heat maps split by functional annotation (<xref ref-type="fig" rid="fig3">Figure 3</xref>). The GSEA pre-ranked function from the Broad's Gene Set Enrichment Analysis (GSEA) (<xref ref-type="bibr" rid="bib64">Subramanian et al., 2005</xref>) suite was used to assess significant enrichment of MSigDB's C2 Reactome gene sets associated with differential expression between cell types. The function was run using a list of genes ranked for differential expression using DESeq2's Wald test statistic with default settings except for: collapse dataset to gene = false enrichment statistic = classic</p></sec><sec id="s4-7"><title>Statistical analysis</title><p>Statistical analysis was performed using Mann Whitney U test, Kruskal-Wallis test followed by Dunn's multiple comparisons test, or Two-Way ANOVA followed by Dunnett's multiple comparisons test on Prism software version 6 (GraphPad). p&lt;0.05 was accepted as a statistically significant difference.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We are grateful to Graham Preece, Philip Hobson and the Flow Cytometry Facility, Jackie Holland and the Biological Research Facility, Richard Mitter and the Bioinformatics Facility, and the Advanced Sequencing Facility at the Francis Crick Institute and the former MRC National Institute for Medical Research, London, UK. We thank Robert Brink, Garvan Institute of Medical Research, New South Wales, Australia, for donating the the C57Bl/6 IgH HEL variable region knock-in construct; Marion Pepper, University of Washington, for her support with the preparation of the MSP1<sub>21</sub> tetramers; and Dinis Calado and Matthew Lewis, Francis Crick Institute, for their critical reading of the manuscript.</p><p>This work was supported by the Francis Crick Institute which receives its core funding from the UK Medical Research Council (FC001101), Cancer Research UK (FC001101) and the Wellcome Trust (FC001101); by the Wellcome Trust (grant reference WT101777MA). Irene Tumwine is the recipient of a Francis Crick PhD studentship.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Validation, Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Formal analysis, Supervision, Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con5"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con6"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Writing—review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Supervision, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Supervision, Validation, Methodology, Funding acquisition, Writing—review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Funding acquisition, Validation, Methodology, Project administration, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: The study was carried out in accordance with the UK Animals (Scientific Procedures) Act 1986, Home Office license 80/2538 and 70/8326. Was approved by the MRC National Institute for Medical Research Ethical Committee, The Francis Crick Institute Ethical Committee, and further approved by the Home Office of the UK upon granting of the HO license.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><object-id pub-id-type="doi">10.7554/eLife.39800.016</object-id><label>Supplementary file 1.</label><caption><title>Mouse homologues to human genes previously described to be either up (↑) or down (↓) regulated in human atypical memory B cells (AMB).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-39800-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><object-id pub-id-type="doi">10.7554/eLife.39800.017</object-id><label>Supplementary file 2.</label><caption><title>List of top 50 Reactome gene sets yielding the highest normalized enrichment score (NES) by GSEA.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-39800-supp2-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.39800.018</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-39800-transrepform-v2.docx"/></supplementary-material><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>RNAseq transcriptome data have been deposited in GEO under accession code GSE115155.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Pérez-Mazliah</surname><given-names>D</given-names></name><name><surname>Gardner</surname><given-names>PJ</given-names></name><name><surname>Schweighoffer</surname><given-names>E</given-names></name><name><surname>McLaughlin</surname><given-names>S</given-names></name><name><surname>Hosking</surname><given-names>C</given-names></name><name><surname>Tumwine</surname><given-names>I</given-names></name><name><surname>Davis</surname><given-names>RS</given-names></name><name><surname>Potocnik</surname><given-names>A</given-names></name><name><surname>Tybulewicz</surname><given-names>V</given-names></name><name><surname>Langhorne</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Plasmodium-specific atypical memory B cells are short-lived activated B cells</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE115155">GSE115155</pub-id></element-citation></p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Achtman</surname> <given-names>AH</given-names></name><name><surname>Stephens</surname> <given-names>R</given-names></name><name><surname>Cadman</surname> <given-names>ET</given-names></name><name><surname>Harrison</surname> <given-names>V</given-names></name><name><surname>Langhorne</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Malaria-specific antibody responses and parasite persistence after infection of mice with Plasmodium chabaudi chabaudi</article-title><source>Parasite Immunology</source><volume>29</volume><fpage>435</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3024.2007.00960.x</pub-id><pub-id pub-id-type="pmid">17727567</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname> <given-names>SM</given-names></name><name><surname>Tomayko</surname> <given-names>MM</given-names></name><name><surname>Ahuja</surname> <given-names>A</given-names></name><name><surname>Haberman</surname> <given-names>AM</given-names></name><name><surname>Shlomchik</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>New markers for murine memory B cells that define mutated and unmutated subsets</article-title><source>The Journal of Experimental Medicine</source><volume>204</volume><fpage>2103</fpage><lpage>2114</lpage><pub-id pub-id-type="doi">10.1084/jem.20062571</pub-id><pub-id pub-id-type="pmid">17698588</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayieko</surname> <given-names>C</given-names></name><name><surname>Maue</surname> <given-names>AC</given-names></name><name><surname>Jura</surname> <given-names>WG</given-names></name><name><surname>Noland</surname> <given-names>GS</given-names></name><name><surname>Ayodo</surname> <given-names>G</given-names></name><name><surname>Rochford</surname> <given-names>R</given-names></name><name><surname>John</surname> <given-names>CC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Changes in B Cell Populations and Merozoite Surface Protein-1-Specific Memory B Cell Responses after Prolonged Absence of Detectable P. falciparum Infection</article-title><source>PLoS ONE</source><volume>8</volume><elocation-id>e67230</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0067230</pub-id><pub-id pub-id-type="pmid">23826242</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnett</surname> <given-names>BE</given-names></name><name><surname>Staupe</surname> <given-names>RP</given-names></name><name><surname>Odorizzi</surname> <given-names>PM</given-names></name><name><surname>Palko</surname> <given-names>O</given-names></name><name><surname>Tomov</surname> <given-names>VT</given-names></name><name><surname>Mahan</surname> <given-names>AE</given-names></name><name><surname>Gunn</surname> <given-names>B</given-names></name><name><surname>Chen</surname> <given-names>D</given-names></name><name><surname>Paley</surname> <given-names>MA</given-names></name><name><surname>Alter</surname> <given-names>G</given-names></name><name><surname>Reiner</surname> <given-names>SL</given-names></name><name><surname>Lauer</surname> <given-names>GM</given-names></name><name><surname>Teijaro</surname> <given-names>JR</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection</article-title><source>The Journal of Immunology</source><volume>197</volume><fpage>1017</fpage><lpage>1022</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1500368</pub-id><pub-id pub-id-type="pmid">27430722</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumgarth</surname> <given-names>N</given-names></name><name><surname>Tung</surname> <given-names>JW</given-names></name><name><surname>Herzenberg</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion</article-title><source>Springer Seminars in Immunopathology</source><volume>26</volume><fpage>347</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1007/s00281-004-0182-2</pub-id><pub-id pub-id-type="pmid">15633017</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumgarth</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The double life of a B-1 cell: self-reactivity selects for protective effector functions</article-title><source>Nature Reviews Immunology</source><volume>11</volume><fpage>34</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1038/nri2901</pub-id><pub-id pub-id-type="pmid">21151033</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname> <given-names>D</given-names></name><name><surname>Cheah</surname> <given-names>MT</given-names></name><name><surname>Franco</surname> <given-names>CB</given-names></name><name><surname>Hosen</surname> <given-names>N</given-names></name><name><surname>Pin</surname> <given-names>CL</given-names></name><name><surname>Sha</surname> <given-names>WC</given-names></name><name><surname>Weissman</surname> <given-names>IL</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Transcriptional profiling of antigen-dependent murine B cell differentiation and memory formation</article-title><source>The Journal of Immunology</source><volume>179</volume><fpage>6808</fpage><lpage>6819</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.10.6808</pub-id><pub-id pub-id-type="pmid">17982071</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname> <given-names>DB</given-names></name><name><surname>Newbold</surname> <given-names>CI</given-names></name><name><surname>Smith</surname> <given-names>CC</given-names></name><name><surname>Brown</surname> <given-names>KN</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Monoclonal antibodies that protect in vivo against Plasmodium chabaudi recognize a 250,000-dalton parasite polypeptide</article-title><source>Infection and Immunity</source><volume>38</volume><fpage>94</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">7141700</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brugat</surname> <given-names>T</given-names></name><name><surname>Reid</surname> <given-names>AJ</given-names></name><name><surname>Lin</surname> <given-names>J</given-names></name><name><surname>Cunningham</surname> <given-names>D</given-names></name><name><surname>Tumwine</surname> <given-names>I</given-names></name><name><surname>Kushinga</surname> <given-names>G</given-names></name><name><surname>McLaughlin</surname> <given-names>S</given-names></name><name><surname>Spence</surname> <given-names>P</given-names></name><name><surname>Böhme</surname> <given-names>U</given-names></name><name><surname>Sanders</surname> <given-names>M</given-names></name><name><surname>Conteh</surname> <given-names>S</given-names></name><name><surname>Bushell</surname> <given-names>E</given-names></name><name><surname>Metcalf</surname> <given-names>T</given-names></name><name><surname>Billker</surname> <given-names>O</given-names></name><name><surname>Duffy</surname> <given-names>PE</given-names></name><name><surname>Newbold</surname> <given-names>C</given-names></name><name><surname>Berriman</surname> <given-names>M</given-names></name><name><surname>Langhorne</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Antibody-independent mechanisms regulate the establishment of chronic Plasmodium infection</article-title><source>Nature Microbiology</source><volume>2</volume><fpage>16276</fpage><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.276</pub-id><pub-id pub-id-type="pmid">28165471</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpio</surname> <given-names>VH</given-names></name><name><surname>Opata</surname> <given-names>MM</given-names></name><name><surname>Montañez</surname> <given-names>ME</given-names></name><name><surname>Banerjee</surname> <given-names>PP</given-names></name><name><surname>Dent</surname> <given-names>AL</given-names></name><name><surname>Stephens</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>IFN-γ and IL-21 Double Producing T Cells Are Bcl6-Independent and Survive into the Memory Phase in Plasmodium chabaudi Infection</article-title><source>PloS ONE</source><volume>10</volume><elocation-id>e0144654</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0144654</pub-id><pub-id pub-id-type="pmid">26646149</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charles</surname> <given-names>ED</given-names></name><name><surname>Brunetti</surname> <given-names>C</given-names></name><name><surname>Marukian</surname> <given-names>S</given-names></name><name><surname>Ritola</surname> <given-names>KD</given-names></name><name><surname>Talal</surname> <given-names>AH</given-names></name><name><surname>Marks</surname> <given-names>K</given-names></name><name><surname>Jacobson</surname> <given-names>IM</given-names></name><name><surname>Rice</surname> <given-names>CM</given-names></name><name><surname>Dustin</surname> <given-names>LB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset</article-title><source>Blood</source><volume>117</volume><fpage>5425</fpage><lpage>5437</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-10-312942</pub-id><pub-id pub-id-type="pmid">21421840</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Lau</surname> <given-names>MC</given-names></name><name><surname>Wong</surname> <given-names>MT</given-names></name><name><surname>Newell</surname> <given-names>EW</given-names></name><name><surname>Poidinger</surname> <given-names>M</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cytofkit: A Bioconductor Package for an Integrated Mass Cytometry Data Analysis Pipeline</article-title><source>PLoS Computational Biology</source><volume>12</volume><elocation-id>e1005112</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005112</pub-id><pub-id pub-id-type="pmid">27662185</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname> <given-names>AG</given-names></name><name><surname>Chen</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Brady</surname> <given-names>GF</given-names></name><name><surname>Ungewitter</surname> <given-names>EK</given-names></name><name><surname>Bradley</surname> <given-names>JK</given-names></name><name><surname>Sackey</surname> <given-names>FN</given-names></name><name><surname>Foster</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Multifunctional regulators of cell growth are differentially expressed in anergic murine B cells</article-title><source>Molecular Immunology</source><volume>44</volume><fpage>1274</fpage><lpage>1285</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2006.06.001</pub-id><pub-id pub-id-type="pmid">16890292</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>RS</given-names></name><name><surname>Stephan</surname> <given-names>RP</given-names></name><name><surname>Chen</surname> <given-names>CC</given-names></name><name><surname>Dennis</surname> <given-names>G</given-names></name><name><surname>Cooper</surname> <given-names>MD</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Differential B cell expression of mouse Fc receptor homologs</article-title><source>International Immunology</source><volume>16</volume><fpage>1343</fpage><lpage>1353</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxh137</pub-id><pub-id pub-id-type="pmid">15302849</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Fc receptor-like molecules</article-title><source>Annual Review of Immunology</source><volume>25</volume><fpage>525</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.25.022106.141541</pub-id><pub-id pub-id-type="pmid">17201682</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Bree</surname> <given-names>GJ</given-names></name><name><surname>Wheatley</surname> <given-names>AK</given-names></name><name><surname>Lynch</surname> <given-names>RM</given-names></name><name><surname>Prabhakaran</surname> <given-names>M</given-names></name><name><surname>Grijsen</surname> <given-names>ML</given-names></name><name><surname>Prins</surname> <given-names>JM</given-names></name><name><surname>Schmidt</surname> <given-names>SD</given-names></name><name><surname>Koup</surname> <given-names>RA</given-names></name><name><surname>Mascola</surname> <given-names>JR</given-names></name><name><surname>McDermott</surname> <given-names>AB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Longitudinal dynamics of the HIV-specific B cell response during intermittent treatment of primary HIV infection</article-title><source>PloS ONE</source><volume>12</volume><elocation-id>e0173577</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0173577</pub-id><pub-id pub-id-type="pmid">28296911</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname> <given-names>A</given-names></name><name><surname>Davis</surname> <given-names>CA</given-names></name><name><surname>Schlesinger</surname> <given-names>F</given-names></name><name><surname>Drenkow</surname> <given-names>J</given-names></name><name><surname>Zaleski</surname> <given-names>C</given-names></name><name><surname>Jha</surname> <given-names>S</given-names></name><name><surname>Batut</surname> <given-names>P</given-names></name><name><surname>Chaisson</surname> <given-names>M</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorfman</surname> <given-names>JR</given-names></name><name><surname>Bejon</surname> <given-names>P</given-names></name><name><surname>Ndungu</surname> <given-names>FM</given-names></name><name><surname>Langhorne</surname> <given-names>J</given-names></name><name><surname>Kortok</surname> <given-names>MM</given-names></name><name><surname>Lowe</surname> <given-names>BS</given-names></name><name><surname>Mwangi</surname> <given-names>TW</given-names></name><name><surname>Williams</surname> <given-names>TN</given-names></name><name><surname>Marsh</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area</article-title><source>The Journal of Infectious Diseases</source><volume>191</volume><fpage>1623</fpage><lpage>1630</lpage><pub-id pub-id-type="doi">10.1086/429671</pub-id><pub-id pub-id-type="pmid">15838788</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrhardt</surname> <given-names>GR</given-names></name><name><surname>Davis</surname> <given-names>RS</given-names></name><name><surname>Hsu</surname> <given-names>JT</given-names></name><name><surname>Leu</surname> <given-names>CM</given-names></name><name><surname>Ehrhardt</surname> <given-names>A</given-names></name><name><surname>Cooper</surname> <given-names>MD</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The inhibitory potential of Fc receptor homolog 4 on memory B cells</article-title><source>PNAS</source><volume>100</volume><fpage>13489</fpage><lpage>13494</lpage><pub-id pub-id-type="doi">10.1073/pnas.1935944100</pub-id><pub-id pub-id-type="pmid">14597715</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrhardt</surname> <given-names>GR</given-names></name><name><surname>Hsu</surname> <given-names>JT</given-names></name><name><surname>Gartland</surname> <given-names>L</given-names></name><name><surname>Leu</surname> <given-names>CM</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Davis</surname> <given-names>RS</given-names></name><name><surname>Cooper</surname> <given-names>MD</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells</article-title><source>The Journal of Experimental Medicine</source><volume>202</volume><fpage>783</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1084/jem.20050879</pub-id><pub-id pub-id-type="pmid">16157685</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enghard</surname> <given-names>P</given-names></name><name><surname>Humrich</surname> <given-names>JY</given-names></name><name><surname>Chu</surname> <given-names>VT</given-names></name><name><surname>Grussie</surname> <given-names>E</given-names></name><name><surname>Hiepe</surname> <given-names>F</given-names></name><name><surname>Burmester</surname> <given-names>GR</given-names></name><name><surname>Radbruch</surname> <given-names>A</given-names></name><name><surname>Berek</surname> <given-names>C</given-names></name><name><surname>Riemekasten</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Class switching and consecutive loss of dsDNA-reactive B1a B cells from the peritoneal cavity during murine lupus development</article-title><source>European Journal of Immunology</source><volume>40</volume><fpage>1809</fpage><lpage>1818</lpage><pub-id pub-id-type="doi">10.1002/eji.200940050</pub-id><pub-id pub-id-type="pmid">20333624</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabregat</surname> <given-names>A</given-names></name><name><surname>Jupe</surname> <given-names>S</given-names></name><name><surname>Matthews</surname> <given-names>L</given-names></name><name><surname>Sidiropoulos</surname> <given-names>K</given-names></name><name><surname>Gillespie</surname> <given-names>M</given-names></name><name><surname>Garapati</surname> <given-names>P</given-names></name><name><surname>Haw</surname> <given-names>R</given-names></name><name><surname>Jassal</surname> <given-names>B</given-names></name><name><surname>Korninger</surname> <given-names>F</given-names></name><name><surname>May</surname> <given-names>B</given-names></name><name><surname>Milacic</surname> <given-names>M</given-names></name><name><surname>Roca</surname> <given-names>CD</given-names></name><name><surname>Rothfels</surname> <given-names>K</given-names></name><name><surname>Sevilla</surname> <given-names>C</given-names></name><name><surname>Shamovsky</surname> <given-names>V</given-names></name><name><surname>Shorser</surname> <given-names>S</given-names></name><name><surname>Varusai</surname> <given-names>T</given-names></name><name><surname>Viteri</surname> <given-names>G</given-names></name><name><surname>Weiser</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>G</given-names></name><name><surname>Stein</surname> <given-names>L</given-names></name><name><surname>Hermjakob</surname> <given-names>H</given-names></name><name><surname>D’Eustachio</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The Reactome Pathway Knowledgebase</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>D649</fpage><lpage>D655</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx1132</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garraud</surname> <given-names>O</given-names></name><name><surname>Borhis</surname> <given-names>G</given-names></name><name><surname>Badr</surname> <given-names>G</given-names></name><name><surname>Degrelle</surname> <given-names>S</given-names></name><name><surname>Pozzetto</surname> <given-names>B</given-names></name><name><surname>Cognasse</surname> <given-names>F</given-names></name><name><surname>Richard</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond</article-title><source>BMC Immunology</source><volume>13</volume><elocation-id>63</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2172-13-63</pub-id><pub-id pub-id-type="pmid">23194300</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Illingworth</surname> <given-names>J</given-names></name><name><surname>Butler</surname> <given-names>NS</given-names></name><name><surname>Roetynck</surname> <given-names>S</given-names></name><name><surname>Mwacharo</surname> <given-names>J</given-names></name><name><surname>Pierce</surname> <given-names>SK</given-names></name><name><surname>Bejon</surname> <given-names>P</given-names></name><name><surname>Crompton</surname> <given-names>PD</given-names></name><name><surname>Marsh</surname> <given-names>K</given-names></name><name><surname>Ndungu</surname> <given-names>FM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion</article-title><source>The Journal of Immunology</source><volume>190</volume><fpage>1038</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1202438</pub-id><pub-id pub-id-type="pmid">23264654</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>G</given-names></name><name><surname>Wu</surname> <given-names>TT</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Kabat Database and its applications: future directions</article-title><source>Nucleic Acids Research</source><volume>29</volume><fpage>205</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1093/nar/29.1.205</pub-id><pub-id pub-id-type="pmid">11125092</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabashima</surname> <given-names>K</given-names></name><name><surname>Haynes</surname> <given-names>NM</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Nutt</surname> <given-names>SL</given-names></name><name><surname>Allende</surname> <given-names>ML</given-names></name><name><surname>Proia</surname> <given-names>RL</given-names></name><name><surname>Cyster</surname> <given-names>JG</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism</article-title><source>The Journal of Experimental Medicine</source><volume>203</volume><fpage>2683</fpage><lpage>2690</lpage><pub-id pub-id-type="doi">10.1084/jem.20061289</pub-id><pub-id pub-id-type="pmid">17101733</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallies</surname> <given-names>A</given-names></name><name><surname>Hasbold</surname> <given-names>J</given-names></name><name><surname>Fairfax</surname> <given-names>K</given-names></name><name><surname>Pridans</surname> <given-names>C</given-names></name><name><surname>Emslie</surname> <given-names>D</given-names></name><name><surname>McKenzie</surname> <given-names>BS</given-names></name><name><surname>Lew</surname> <given-names>AM</given-names></name><name><surname>Corcoran</surname> <given-names>LM</given-names></name><name><surname>Hodgkin</surname> <given-names>PD</given-names></name><name><surname>Tarlinton</surname> <given-names>DM</given-names></name><name><surname>Nutt</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1</article-title><source>Immunity</source><volume>26</volume><fpage>555</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2007.04.007</pub-id><pub-id pub-id-type="pmid">17509907</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kardava</surname> <given-names>L</given-names></name><name><surname>Moir</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>Ho</surname> <given-names>J</given-names></name><name><surname>Buckner</surname> <given-names>CM</given-names></name><name><surname>Posada</surname> <given-names>JG</given-names></name><name><surname>O'Shea</surname> <given-names>MA</given-names></name><name><surname>Roby</surname> <given-names>G</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Sohn</surname> <given-names>HW</given-names></name><name><surname>Chun</surname> <given-names>TW</given-names></name><name><surname>Pierce</surname> <given-names>SK</given-names></name><name><surname>Fauci</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors</article-title><source>Journal of Clinical Investigation</source><volume>121</volume><fpage>2614</fpage><lpage>2624</lpage><pub-id pub-id-type="doi">10.1172/JCI45685</pub-id><pub-id pub-id-type="pmid">21633172</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kardava</surname> <given-names>L</given-names></name><name><surname>Moir</surname> <given-names>S</given-names></name><name><surname>Shah</surname> <given-names>N</given-names></name><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>Wilson</surname> <given-names>R</given-names></name><name><surname>Buckner</surname> <given-names>CM</given-names></name><name><surname>Santich</surname> <given-names>BH</given-names></name><name><surname>Kim</surname> <given-names>LJ</given-names></name><name><surname>Spurlin</surname> <given-names>EE</given-names></name><name><surname>Nelson</surname> <given-names>AK</given-names></name><name><surname>Wheatley</surname> <given-names>AK</given-names></name><name><surname>Harvey</surname> <given-names>CJ</given-names></name><name><surname>McDermott</surname> <given-names>AB</given-names></name><name><surname>Wucherpfennig</surname> <given-names>KW</given-names></name><name><surname>Chun</surname> <given-names>TW</given-names></name><name><surname>Tsang</surname> <given-names>JS</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Fauci</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals</article-title><source>Journal of Clinical Investigation</source><volume>124</volume><fpage>3252</fpage><lpage>3262</lpage><pub-id pub-id-type="doi">10.1172/JCI74351</pub-id><pub-id pub-id-type="pmid">24892810</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knox</surname> <given-names>JJ</given-names></name><name><surname>Buggert</surname> <given-names>M</given-names></name><name><surname>Kardava</surname> <given-names>L</given-names></name><name><surname>Seaton</surname> <given-names>KE</given-names></name><name><surname>Eller</surname> <given-names>MA</given-names></name><name><surname>Canaday</surname> <given-names>DH</given-names></name><name><surname>Robb</surname> <given-names>ML</given-names></name><name><surname>Ostrowski</surname> <given-names>MA</given-names></name><name><surname>Deeks</surname> <given-names>SG</given-names></name><name><surname>Slifka</surname> <given-names>MK</given-names></name><name><surname>Tomaras</surname> <given-names>GD</given-names></name><name><surname>Moir</surname> <given-names>S</given-names></name><name><surname>Moody</surname> <given-names>MA</given-names></name><name><surname>Betts</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response</article-title><source>JCI Insight</source><volume>2</volume><pub-id pub-id-type="doi">10.1172/jci.insight.92943</pub-id><pub-id pub-id-type="pmid">28422752</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knox</surname> <given-names>JJ</given-names></name><name><surname>Kaplan</surname> <given-names>DE</given-names></name><name><surname>Betts</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>T-bet-expressing B cells during HIV and HCV infections</article-title><source>Cellular Immunology</source><volume>321</volume><fpage>26</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2017.04.012</pub-id><pub-id pub-id-type="pmid">28739077</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnamurty</surname> <given-names>AT</given-names></name><name><surname>Thouvenel</surname> <given-names>CD</given-names></name><name><surname>Portugal</surname> <given-names>S</given-names></name><name><surname>Keitany</surname> <given-names>GJ</given-names></name><name><surname>Kim</surname> <given-names>KS</given-names></name><name><surname>Holder</surname> <given-names>A</given-names></name><name><surname>Crompton</surname> <given-names>PD</given-names></name><name><surname>Rawlings</surname> <given-names>DJ</given-names></name><name><surname>Pepper</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Somatically Hypermutated Plasmodium-Specific IgM</article-title><source>Immunity</source><fpage>402</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.06.014</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalor</surname> <given-names>PA</given-names></name><name><surname>Nossal</surname> <given-names>GJ</given-names></name><name><surname>Sanderson</surname> <given-names>RD</given-names></name><name><surname>McHeyzer-Williams</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Functional and molecular characterization of single, (4-hydroxy-3-nitrophenyl)acetyl (NP)-specific, IgG1+ B cells from antibody-secreting and memory B cell pathways in the C57BL/6 immune response to NP</article-title><source>European Journal of Immunology</source><volume>22</volume><fpage>3001</fpage><lpage>3011</lpage><pub-id pub-id-type="doi">10.1002/eji.1830221136</pub-id><pub-id pub-id-type="pmid">1425924</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname> <given-names>JH</given-names></name><name><surname>Simonds</surname> <given-names>EF</given-names></name><name><surname>Bendall</surname> <given-names>SC</given-names></name><name><surname>Davis</surname> <given-names>KL</given-names></name><name><surname>Amir</surname> <given-names>el-AD</given-names></name><name><surname>Tadmor</surname> <given-names>MD</given-names></name><name><surname>Litvin</surname> <given-names>O</given-names></name><name><surname>Fienberg</surname> <given-names>HG</given-names></name><name><surname>Jager</surname> <given-names>A</given-names></name><name><surname>Zunder</surname> <given-names>ER</given-names></name><name><surname>Finck</surname> <given-names>R</given-names></name><name><surname>Gedman</surname> <given-names>AL</given-names></name><name><surname>Radtke</surname> <given-names>I</given-names></name><name><surname>Downing</surname> <given-names>JR</given-names></name><name><surname>Pe'er</surname> <given-names>D</given-names></name><name><surname>Nolan</surname> <given-names>GP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis</article-title><source>Cell</source><volume>162</volume><fpage>184</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.05.047</pub-id><pub-id pub-id-type="pmid">26095251</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>B</given-names></name><name><surname>Dewey</surname> <given-names>CN</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome</article-title><source>BMC Bioinformatics</source><volume>12</volume><elocation-id>323</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-12-323</pub-id><pub-id pub-id-type="pmid">21816040</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Borrego</surname> <given-names>F</given-names></name><name><surname>Nagata</surname> <given-names>S</given-names></name><name><surname>Tolnay</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Fc receptor-like 5 expression distinguishes two distinct subsets of human circulating tissue-like memory b cells</article-title><source>The Journal of Immunology</source><volume>196</volume><fpage>4064</fpage><lpage>4074</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1501027</pub-id><pub-id pub-id-type="pmid">27076679</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Anders</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>31</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cutadapt removes adapter sequences from high-throughput sequencing reads</article-title><source>EMBnet.journal</source><volume>17</volume><fpage>10</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.14806/ej.17.1.200</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moir</surname> <given-names>S</given-names></name><name><surname>Ho</surname> <given-names>J</given-names></name><name><surname>Malaspina</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>DiPoto</surname> <given-names>AC</given-names></name><name><surname>O'Shea</surname> <given-names>MA</given-names></name><name><surname>Roby</surname> <given-names>G</given-names></name><name><surname>Kottilil</surname> <given-names>S</given-names></name><name><surname>Arthos</surname> <given-names>J</given-names></name><name><surname>Proschan</surname> <given-names>MA</given-names></name><name><surname>Chun</surname> <given-names>TW</given-names></name><name><surname>Fauci</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals</article-title><source>The Journal of Experimental Medicine</source><volume>205</volume><fpage>1797</fpage><lpage>1805</lpage><pub-id pub-id-type="doi">10.1084/jem.20072683</pub-id><pub-id pub-id-type="pmid">18625747</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muellenbeck</surname> <given-names>MF</given-names></name><name><surname>Ueberheide</surname> <given-names>B</given-names></name><name><surname>Amulic</surname> <given-names>B</given-names></name><name><surname>Epp</surname> <given-names>A</given-names></name><name><surname>Fenyo</surname> <given-names>D</given-names></name><name><surname>Busse</surname> <given-names>CE</given-names></name><name><surname>Esen</surname> <given-names>M</given-names></name><name><surname>Theisen</surname> <given-names>M</given-names></name><name><surname>Mordmüller</surname> <given-names>B</given-names></name><name><surname>Wardemann</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies</article-title><source>The Journal of Experimental Medicine</source><volume>210</volume><fpage>389</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1084/jem.20121970</pub-id><pub-id pub-id-type="pmid">23319701</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naradikian</surname> <given-names>MS</given-names></name><name><surname>Hao</surname> <given-names>Y</given-names></name><name><surname>Cancro</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>Age-associated B cells: key mediators of both protective and autoreactive humoral responses</article-title><source>Immunological Reviews</source><volume>269</volume><fpage>118</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1111/imr.12380</pub-id><pub-id pub-id-type="pmid">26683149</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naradikian</surname> <given-names>MS</given-names></name><name><surname>Myles</surname> <given-names>A</given-names></name><name><surname>Beiting</surname> <given-names>DP</given-names></name><name><surname>Roberts</surname> <given-names>KJ</given-names></name><name><surname>Dawson</surname> <given-names>L</given-names></name><name><surname>Herati</surname> <given-names>RS</given-names></name><name><surname>Bengsch</surname> <given-names>B</given-names></name><name><surname>Linderman</surname> <given-names>SL</given-names></name><name><surname>Stelekati</surname> <given-names>E</given-names></name><name><surname>Spolski</surname> <given-names>R</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name><name><surname>Hunter</surname> <given-names>C</given-names></name><name><surname>Hensley</surname> <given-names>SE</given-names></name><name><surname>Leonard</surname> <given-names>WJ</given-names></name><name><surname>Cancro</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells</article-title><source>The Journal of Immunology</source><volume>197</volume><fpage>1023</fpage><lpage>1028</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1600522</pub-id><pub-id pub-id-type="pmid">27430719</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ndungu</surname> <given-names>FM</given-names></name><name><surname>Cadman</surname> <given-names>ET</given-names></name><name><surname>Coulcher</surname> <given-names>J</given-names></name><name><surname>Nduati</surname> <given-names>E</given-names></name><name><surname>Couper</surname> <given-names>E</given-names></name><name><surname>Macdonald</surname> <given-names>DW</given-names></name><name><surname>Ng</surname> <given-names>D</given-names></name><name><surname>Langhorne</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Functional memory B cells and long-lived plasma cells are generated after a single Plasmodium chabaudi infection in mice</article-title><source>PLoS Pathogens</source><volume>5</volume><elocation-id>e1000690</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000690</pub-id><pub-id pub-id-type="pmid">20011127</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ndungu</surname> <given-names>FM</given-names></name><name><surname>Olotu</surname> <given-names>A</given-names></name><name><surname>Mwacharo</surname> <given-names>J</given-names></name><name><surname>Nyonda</surname> <given-names>M</given-names></name><name><surname>Apfeld</surname> <given-names>J</given-names></name><name><surname>Mramba</surname> <given-names>LK</given-names></name><name><surname>Fegan</surname> <given-names>GW</given-names></name><name><surname>Bejon</surname> <given-names>P</given-names></name><name><surname>Marsh</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children</article-title><source>PNAS</source><volume>109</volume><fpage>8247</fpage><lpage>8252</lpage><pub-id pub-id-type="doi">10.1073/pnas.1200472109</pub-id><pub-id pub-id-type="pmid">22566630</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ndungu</surname> <given-names>FM</given-names></name><name><surname>Lundblom</surname> <given-names>K</given-names></name><name><surname>Rono</surname> <given-names>J</given-names></name><name><surname>Illingworth</surname> <given-names>J</given-names></name><name><surname>Eriksson</surname> <given-names>S</given-names></name><name><surname>Färnert</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Long-lived Plasmodium falciparum specific memory B cells in naturally exposed Swedish travelers</article-title><source>European Journal of Immunology</source><volume>43</volume><fpage>2919</fpage><lpage>2929</lpage><pub-id pub-id-type="doi">10.1002/eji.201343630</pub-id><pub-id pub-id-type="pmid">23881859</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Gorman</surname> <given-names>S</given-names></name><name><surname>Dagenais</surname> <given-names>NA</given-names></name><name><surname>Qian</surname> <given-names>M</given-names></name><name><surname>Marchuk</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells</article-title><source>PNAS</source><volume>94</volume><fpage>14602</fpage><lpage>14607</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.26.14602</pub-id><pub-id pub-id-type="pmid">9405659</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obeng-Adjei</surname> <given-names>N</given-names></name><name><surname>Portugal</surname> <given-names>S</given-names></name><name><surname>Tran</surname> <given-names>TM</given-names></name><name><surname>Yazew</surname> <given-names>TB</given-names></name><name><surname>Skinner</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Jain</surname> <given-names>A</given-names></name><name><surname>Felgner</surname> <given-names>PL</given-names></name><name><surname>Doumbo</surname> <given-names>OK</given-names></name><name><surname>Kayentao</surname> <given-names>K</given-names></name><name><surname>Ongoiba</surname> <given-names>A</given-names></name><name><surname>Traore</surname> <given-names>B</given-names></name><name><surname>Crompton</surname> <given-names>PD</given-names></name><name><surname>Yeste</surname> <given-names>A</given-names></name><name><surname>Mascanfroni</surname> <given-names>ID</given-names></name><name><surname>Nadeau</surname> <given-names>M</given-names></name><name><surname>Burns</surname> <given-names>EJ</given-names></name><name><surname>Tukpah</surname> <given-names>A-M</given-names></name><name><surname>Santiago</surname> <given-names>A</given-names></name><name><surname>Wu</surname> <given-names>C</given-names></name><name><surname>Patel</surname> <given-names>B</given-names></name><name><surname>Kumar</surname> <given-names>D</given-names></name><name><surname>Quintana</surname> <given-names>FJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Circulating th1-cell-type tfh cells that exhibit impaired b cell help are preferentially activated during acute malaria in children</article-title><source>Cell Reports</source><volume>13</volume><fpage>425</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.09.004</pub-id><pub-id pub-id-type="pmid">26440897</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obeng-Adjei</surname> <given-names>N</given-names></name><name><surname>Portugal</surname> <given-names>S</given-names></name><name><surname>Holla</surname> <given-names>P</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Sohn</surname> <given-names>H</given-names></name><name><surname>Ambegaonkar</surname> <given-names>A</given-names></name><name><surname>Skinner</surname> <given-names>J</given-names></name><name><surname>Bowyer</surname> <given-names>G</given-names></name><name><surname>Doumbo</surname> <given-names>OK</given-names></name><name><surname>Traore</surname> <given-names>B</given-names></name><name><surname>Pierce</surname> <given-names>SK</given-names></name><name><surname>Crompton</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Malaria-induced interferon-γ drives the expansion of Tbethi atypical memory B cells</article-title><source>PLoS Pathogens</source><volume>13</volume><elocation-id>e1006576</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006576</pub-id><pub-id pub-id-type="pmid">28953967</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pérez-Mazliah</surname> <given-names>D</given-names></name><name><surname>Ng</surname> <given-names>DH</given-names></name><name><surname>Freitas do Rosário</surname> <given-names>AP</given-names></name><name><surname>McLaughlin</surname> <given-names>S</given-names></name><name><surname>Mastelic-Gavillet</surname> <given-names>B</given-names></name><name><surname>Sodenkamp</surname> <given-names>J</given-names></name><name><surname>Kushinga</surname> <given-names>G</given-names></name><name><surname>Langhorne</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Disruption of IL-21 signaling affects T cell-B cell interactions and abrogates protective humoral immunity to malaria</article-title><source>PLoS Pathogens</source><volume>11</volume><elocation-id>e1004715</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004715</pub-id><pub-id pub-id-type="pmid">25763578</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phan</surname> <given-names>TG</given-names></name><name><surname>Amesbury</surname> <given-names>M</given-names></name><name><surname>Gardam</surname> <given-names>S</given-names></name><name><surname>Crosbie</surname> <given-names>J</given-names></name><name><surname>Hasbold</surname> <given-names>J</given-names></name><name><surname>Hodgkin</surname> <given-names>PD</given-names></name><name><surname>Basten</surname> <given-names>A</given-names></name><name><surname>Brink</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells</article-title><source>The Journal of Experimental Medicine</source><volume>197</volume><fpage>845</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1084/jem.20022144</pub-id><pub-id pub-id-type="pmid">12668643</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pillai</surname> <given-names>S</given-names></name><name><surname>Cariappa</surname> <given-names>A</given-names></name><name><surname>Moran</surname> <given-names>ST</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Marginal zone B cells</article-title><source>Annual Review of Immunology</source><volume>23</volume><fpage>161</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.23.021704.115728</pub-id><pub-id pub-id-type="pmid">15771569</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portugal</surname> <given-names>S</given-names></name><name><surname>Pierce</surname> <given-names>SK</given-names></name><name><surname>Crompton</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Young lives lost as B cells falter: what we are learning about antibody responses in malaria</article-title><source>The Journal of Immunology</source><volume>190</volume><fpage>3039</fpage><lpage>3046</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1203067</pub-id><pub-id pub-id-type="pmid">23526829</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portugal</surname> <given-names>S</given-names></name><name><surname>Tipton</surname> <given-names>CM</given-names></name><name><surname>Sohn</surname> <given-names>H</given-names></name><name><surname>Kone</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Skinner</surname> <given-names>J</given-names></name><name><surname>Virtaneva</surname> <given-names>K</given-names></name><name><surname>Sturdevant</surname> <given-names>DE</given-names></name><name><surname>Porcella</surname> <given-names>SF</given-names></name><name><surname>Doumbo</surname> <given-names>OK</given-names></name><name><surname>Doumbo</surname> <given-names>S</given-names></name><name><surname>Kayentao</surname> <given-names>K</given-names></name><name><surname>Ongoiba</surname> <given-names>A</given-names></name><name><surname>Traore</surname> <given-names>B</given-names></name><name><surname>Sanz</surname> <given-names>I</given-names></name><name><surname>Pierce</surname> <given-names>SK</given-names></name><name><surname>Crompton</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Malaria-associated atypical memory B cells exhibit markedly reduced B cell receptor signaling and effector function</article-title><source>eLife</source><volume>4</volume><elocation-id>e07218</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.07218</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portugal</surname> <given-names>S</given-names></name><name><surname>Obeng-Adjei</surname> <given-names>N</given-names></name><name><surname>Moir</surname> <given-names>S</given-names></name><name><surname>Crompton</surname> <given-names>PD</given-names></name><name><surname>Pierce</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Atypical memory B cells in human chronic infectious diseases: An interim report</article-title><source>Cellular Immunology</source><volume>321</volume><fpage>18</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2017.07.003</pub-id><pub-id pub-id-type="pmid">28735813</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quin</surname> <given-names>SJ</given-names></name><name><surname>Langhorne</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Different regions of the malaria merozoite surface protein 1 of Plasmodium chabaudi elicit distinct T-cell and antibody isotype responses</article-title><source>Infection and Immunity</source><volume>69</volume><fpage>2245</fpage><lpage>2251</lpage><pub-id pub-id-type="doi">10.1128/IAI.69.4.2245-2251.2001</pub-id><pub-id pub-id-type="pmid">11254580</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridderstad</surname> <given-names>A</given-names></name><name><surname>Tarlinton</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Kinetics of establishing the memory B cell population as revealed by CD38 expression</article-title><source>Journal of Immunology</source><volume>160</volume><fpage>4688</fpage><lpage>4695</lpage></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Correa</surname> <given-names>J</given-names></name><name><surname>Guthmiller</surname> <given-names>JJ</given-names></name><name><surname>Vijay</surname> <given-names>R</given-names></name><name><surname>Fernandez-Arias</surname> <given-names>C</given-names></name><name><surname>Pardo-Ruge</surname> <given-names>MA</given-names></name><name><surname>Gonzalez</surname> <given-names>S</given-names></name><name><surname>Butler</surname> <given-names>NS</given-names></name><name><surname>Rodriguez</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Plasmodium DNA-mediated TLR9 activation of T-bet<sup>+</sup> B cells contributes to autoimmune anaemia during malaria</article-title><source>Nature Communications</source><volume>8</volume><fpage>1282</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-01476-6</pub-id><pub-id pub-id-type="pmid">29101363</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubtsov</surname> <given-names>AV</given-names></name><name><surname>Marrack</surname> <given-names>P</given-names></name><name><surname>Rubtsova</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>T-bet expressing B cells - Novel target for autoimmune therapies?</article-title><source>Cellular Immunology</source><volume>321</volume><fpage>35</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2017.04.011</pub-id><pub-id pub-id-type="pmid">28641866</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubtsova</surname> <given-names>K</given-names></name><name><surname>Rubtsov</surname> <given-names>AV</given-names></name><name><surname>van Dyk</surname> <given-names>LF</given-names></name><name><surname>Kappler</surname> <given-names>JW</given-names></name><name><surname>Marrack</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance</article-title><source>PNAS</source><volume>110</volume><fpage>E3216</fpage><lpage>E3224</lpage><pub-id pub-id-type="doi">10.1073/pnas.1312348110</pub-id><pub-id pub-id-type="pmid">23922396</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell Knode</surname> <given-names>LM</given-names></name><name><surname>Naradikian</surname> <given-names>MS</given-names></name><name><surname>Myles</surname> <given-names>A</given-names></name><name><surname>Scholz</surname> <given-names>JL</given-names></name><name><surname>Hao</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>D</given-names></name><name><surname>Ford</surname> <given-names>ML</given-names></name><name><surname>Tobias</surname> <given-names>JW</given-names></name><name><surname>Cancro</surname> <given-names>MP</given-names></name><name><surname>Gearhart</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Age-associated b cells express a diverse repertoire of v<sub>h</sub> and vκ genes wit<sub>h</sub> somatic hypermutation</article-title><source>The Journal of Immunology</source><volume>198</volume><fpage>1921</fpage><lpage>1927</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1601106</pub-id><pub-id pub-id-type="pmid">28093524</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname> <given-names>J</given-names></name><name><surname>Rosenberg</surname> <given-names>N</given-names></name><name><surname>Burakoff</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Expression and ontogeny of CD2 on murine B cells</article-title><source>Journal of Immunology</source><volume>144</volume><fpage>2925</fpage><lpage>2930</lpage><pub-id pub-id-type="doi">10.1002/eji.1830190722</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spence</surname> <given-names>PJ</given-names></name><name><surname>Jarra</surname> <given-names>W</given-names></name><name><surname>Lévy</surname> <given-names>P</given-names></name><name><surname>Nahrendorf</surname> <given-names>W</given-names></name><name><surname>Langhorne</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mosquito transmission of the rodent malaria parasite Plasmodium chabaudi</article-title><source>Malaria Journal</source><volume>11</volume><elocation-id>407</elocation-id><pub-id pub-id-type="doi">10.1186/1475-2875-11-407</pub-id><pub-id pub-id-type="pmid">23217144</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spence</surname> <given-names>PJ</given-names></name><name><surname>Jarra</surname> <given-names>W</given-names></name><name><surname>Lévy</surname> <given-names>P</given-names></name><name><surname>Reid</surname> <given-names>AJ</given-names></name><name><surname>Chappell</surname> <given-names>L</given-names></name><name><surname>Brugat</surname> <given-names>T</given-names></name><name><surname>Sanders</surname> <given-names>M</given-names></name><name><surname>Berriman</surname> <given-names>M</given-names></name><name><surname>Langhorne</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Vector transmission regulates immune control of Plasmodium virulence</article-title><source>Nature</source><volume>498</volume><fpage>228</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1038/nature12231</pub-id><pub-id pub-id-type="pmid">23719378</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname> <given-names>A</given-names></name><name><surname>Tamayo</surname> <given-names>P</given-names></name><name><surname>Mootha</surname> <given-names>VK</given-names></name><name><surname>Mukherjee</surname> <given-names>S</given-names></name><name><surname>Ebert</surname> <given-names>BL</given-names></name><name><surname>Gillette</surname> <given-names>MA</given-names></name><name><surname>Paulovich</surname> <given-names>A</given-names></name><name><surname>Pomeroy</surname> <given-names>SL</given-names></name><name><surname>Golub</surname> <given-names>TR</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Mesirov</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname> <given-names>RT</given-names></name><name><surname>Kim</surname> <given-names>CC</given-names></name><name><surname>Fontana</surname> <given-names>MF</given-names></name><name><surname>Feeney</surname> <given-names>ME</given-names></name><name><surname>Jagannathan</surname> <given-names>P</given-names></name><name><surname>Boyle</surname> <given-names>MJ</given-names></name><name><surname>Drakeley</surname> <given-names>CJ</given-names></name><name><surname>Ssewanyana</surname> <given-names>I</given-names></name><name><surname>Nankya</surname> <given-names>F</given-names></name><name><surname>Mayanja-Kizza</surname> <given-names>H</given-names></name><name><surname>Dorsey</surname> <given-names>G</given-names></name><name><surname>Greenhouse</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>FCRL5 Delineates Functionally Impaired Memory B Cells Associated with Plasmodium falciparum Exposure</article-title><source>PLoS Pathogens</source><volume>11</volume><elocation-id>e1004894</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004894</pub-id><pub-id pub-id-type="pmid">25993340</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname> <given-names>RT</given-names></name><name><surname>Ssewanyana</surname> <given-names>I</given-names></name><name><surname>Wamala</surname> <given-names>S</given-names></name><name><surname>Nankya</surname> <given-names>F</given-names></name><name><surname>Jagannathan</surname> <given-names>P</given-names></name><name><surname>Tappero</surname> <given-names>JW</given-names></name><name><surname>Mayanja-Kizza</surname> <given-names>H</given-names></name><name><surname>Muhindo</surname> <given-names>MK</given-names></name><name><surname>Arinaitwe</surname> <given-names>E</given-names></name><name><surname>Kamya</surname> <given-names>M</given-names></name><name><surname>Dorsey</surname> <given-names>G</given-names></name><name><surname>Feeney</surname> <given-names>ME</given-names></name><name><surname>Riley</surname> <given-names>EM</given-names></name><name><surname>Drakeley</surname> <given-names>CJ</given-names></name><name><surname>Greenhouse</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>B cell sub-types following acute malaria and associations with clinical immunity</article-title><source>Malaria Journal</source><volume>15</volume><pub-id pub-id-type="doi">10.1186/s12936-016-1190-0</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taki</surname> <given-names>S</given-names></name><name><surname>Meiering</surname> <given-names>M</given-names></name><name><surname>Rajewsky</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Targeted insertion of a variable region gene into the immunoglobulin heavy chain locus</article-title><source>Science</source><volume>262</volume><fpage>1268</fpage><lpage>1271</lpage><pub-id pub-id-type="doi">10.1126/science.8235657</pub-id><pub-id pub-id-type="pmid">8235657</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname> <given-names>JJ</given-names></name><name><surname>Martinez</surname> <given-names>RJ</given-names></name><name><surname>Titcombe</surname> <given-names>PJ</given-names></name><name><surname>Barsness</surname> <given-names>LO</given-names></name><name><surname>Thomas</surname> <given-names>SR</given-names></name><name><surname>Zhang</surname> <given-names>N</given-names></name><name><surname>Katzman</surname> <given-names>SD</given-names></name><name><surname>Jenkins</surname> <given-names>MK</given-names></name><name><surname>Mueller</surname> <given-names>DL</given-names></name><name><surname>Martinez</surname> <given-names>RJ</given-names></name><name><surname>Mueller</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen</article-title><source>The Journal of experimental medicine</source><volume>209</volume><fpage>2065</fpage><lpage>2077</lpage><pub-id pub-id-type="doi">10.1084/jem.20112272</pub-id><pub-id pub-id-type="pmid">23071255</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomayko</surname> <given-names>MM</given-names></name><name><surname>Steinel</surname> <given-names>NC</given-names></name><name><surname>Anderson</surname> <given-names>SM</given-names></name><name><surname>Shlomchik</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cutting edge: Hierarchy of maturity of murine memory B cell subsets</article-title><source>The Journal of Immunology</source><volume>185</volume><fpage>7146</fpage><lpage>7150</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1002163</pub-id><pub-id pub-id-type="pmid">21078902</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Maaten</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Visualizing Data using t-SNE</article-title><source>Journal of Machine Learning Research</source><volume>9</volume><fpage>2579</fpage><lpage>2605</lpage></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname> <given-names>GE</given-names></name><name><surname>Crompton</surname> <given-names>PD</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Walsh</surname> <given-names>LA</given-names></name><name><surname>Moir</surname> <given-names>S</given-names></name><name><surname>Traore</surname> <given-names>B</given-names></name><name><surname>Kayentao</surname> <given-names>K</given-names></name><name><surname>Ongoiba</surname> <given-names>A</given-names></name><name><surname>Doumbo</surname> <given-names>OK</given-names></name><name><surname>Pierce</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area</article-title><source>The Journal of Immunology</source><volume>183</volume><fpage>2176</fpage><lpage>2182</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0901297</pub-id><pub-id pub-id-type="pmid">19592645</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname> <given-names>GE</given-names></name><name><surname>Traore</surname> <given-names>B</given-names></name><name><surname>Kayentao</surname> <given-names>K</given-names></name><name><surname>Ongoiba</surname> <given-names>A</given-names></name><name><surname>Doumbo</surname> <given-names>S</given-names></name><name><surname>Doumtabe</surname> <given-names>D</given-names></name><name><surname>Kone</surname> <given-names>Y</given-names></name><name><surname>Dia</surname> <given-names>S</given-names></name><name><surname>Guindo</surname> <given-names>A</given-names></name><name><surname>Traore</surname> <given-names>A</given-names></name><name><surname>Huang</surname> <given-names>CY</given-names></name><name><surname>Miura</surname> <given-names>K</given-names></name><name><surname>Mircetic</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Baughman</surname> <given-names>A</given-names></name><name><surname>Narum</surname> <given-names>DL</given-names></name><name><surname>Miller</surname> <given-names>LH</given-names></name><name><surname>Doumbo</surname> <given-names>OK</given-names></name><name><surname>Pierce</surname> <given-names>SK</given-names></name><name><surname>Crompton</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections</article-title><source>PLoS Pathogens</source><volume>6</volume><elocation-id>e1000912</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000912</pub-id><pub-id pub-id-type="pmid">20502681</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname> <given-names>GE</given-names></name><name><surname>Clark</surname> <given-names>EH</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Traore</surname> <given-names>B</given-names></name><name><surname>Kayentao</surname> <given-names>K</given-names></name><name><surname>Ongoiba</surname> <given-names>A</given-names></name><name><surname>Hernandez</surname> <given-names>JN</given-names></name><name><surname>Doumbo</surname> <given-names>OK</given-names></name><name><surname>Pierce</surname> <given-names>SK</given-names></name><name><surname>Branch</surname> <given-names>OH</given-names></name><name><surname>Crompton</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A positive correlation between atypical memory B cells and Plasmodium falciparum transmission intensity in cross-sectional studies in Peru and Mali</article-title><source>PLoS ONE</source><volume>6</volume><elocation-id>e15983</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0015983</pub-id><pub-id pub-id-type="pmid">21264245</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wipasa</surname> <given-names>J</given-names></name><name><surname>Suphavilai</surname> <given-names>C</given-names></name><name><surname>Okell</surname> <given-names>LC</given-names></name><name><surname>Cook</surname> <given-names>J</given-names></name><name><surname>Corran</surname> <given-names>PH</given-names></name><name><surname>Thaikla</surname> <given-names>K</given-names></name><name><surname>Liewsaree</surname> <given-names>W</given-names></name><name><surname>Riley</surname> <given-names>EM</given-names></name><name><surname>Hafalla</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax</article-title><source>PLoS Pathogens</source><volume>6</volume><elocation-id>e1000770</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000770</pub-id><pub-id pub-id-type="pmid">20174609</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Won</surname> <given-names>WJ</given-names></name><name><surname>Foote</surname> <given-names>JB</given-names></name><name><surname>Odom</surname> <given-names>MR</given-names></name><name><surname>Pan</surname> <given-names>J</given-names></name><name><surname>Kearney</surname> <given-names>JF</given-names></name><name><surname>Davis</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Fc receptor homolog 3 is a novel immunoregulatory marker of marginal zone and B1 B cells</article-title><source>The Journal of Immunology</source><volume>177</volume><fpage>6815</fpage><lpage>6823</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.177.10.6815</pub-id><pub-id pub-id-type="pmid">17082595</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname> <given-names>F</given-names></name><name><surname>Ardman</surname> <given-names>B</given-names></name><name><surname>Shinkai</surname> <given-names>Y</given-names></name><name><surname>Lansford</surname> <given-names>R</given-names></name><name><surname>Blackwell</surname> <given-names>TK</given-names></name><name><surname>Mendelsohn</surname> <given-names>M</given-names></name><name><surname>Rolink</surname> <given-names>A</given-names></name><name><surname>Melchers</surname> <given-names>F</given-names></name><name><surname>Alt</surname> <given-names>FW</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Influence of immunoglobulin heavy- and light-chain expression on B-cell differentiation</article-title><source>Genes &amp; Development</source><volume>8</volume><fpage>1043</fpage><lpage>1057</lpage><pub-id pub-id-type="doi">10.1101/gad.8.9.1043</pub-id><pub-id pub-id-type="pmid">7926786</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>Z</given-names></name><name><surname>Li</surname> <given-names>R</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Zhou</surname> <given-names>T</given-names></name><name><surname>Davis</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling</article-title><source>PNAS</source><volume>110</volume><fpage>E1282</fpage><lpage>E1290</lpage><pub-id pub-id-type="doi">10.1073/pnas.1215156110</pub-id><pub-id pub-id-type="pmid">23509253</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zouali</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Marginal zone B-cells</article-title><source>A Gatekeeper of Innate Immunity</source><volume>2</volume><pub-id pub-id-type="doi">10.3389/fimmu.2011.00063</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuccarino-Catania</surname> <given-names>GV</given-names></name><name><surname>Sadanand</surname> <given-names>S</given-names></name><name><surname>Weisel</surname> <given-names>FJ</given-names></name><name><surname>Tomayko</surname> <given-names>MM</given-names></name><name><surname>Meng</surname> <given-names>H</given-names></name><name><surname>Kleinstein</surname> <given-names>SH</given-names></name><name><surname>Good-Jacobson</surname> <given-names>KL</given-names></name><name><surname>Shlomchik</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype</article-title><source>Nature Immunology</source><volume>15</volume><fpage>631</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1038/ni.2914</pub-id><pub-id pub-id-type="pmid">24880458</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.39800.022</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Batista</surname><given-names>Facundo D</given-names></name><role>Reviewing Editor</role><aff><institution>Ragon Institute of MGH, MIT and Harvard</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;<italic>Plasmodium</italic>-specific atypical memory B cells are short-lived activated B cells&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by Michel Nussenzweig as the Senior Editor, a Reviewing Editor, and three reviewers. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Essential revisions:</p><p>All three reviewers agreed that the study is of sufficient general interest but that the manuscript requires significant re-organization and rewriting to clarify the various points that they have collectively raised. For this, I am copying the reviewers’ comments below. While this will not require new experimentation, it will be important that you revise the manuscript to incorporate and address all reviewers concerns.</p><p><italic>Reviewer #2:</italic></p><p>Atypical memory B cells (AMB) are a feature of <italic>Plasmodium</italic> (malaria) infections and B cells with a similar phenotype (CD21<sup>lo</sup>, FCRL<sup>hi</sup> etc.) have been identified in many other human infections and immuno-deficiencies as well as in aging mice. There is still much conjecture around the function and of AMBs and what triggers their development, partly because they are frequently described in the context of active human infections. Studies in which the genesis and fate of AMBs can be studied in a more controlled manner are likely to provide greater insight into the nature of these cells.</p><p>In this manuscript, the authors have developed a novel BCR/Ig knock-in mouse in which B cells express a heavy chain recognising the <italic>P. chabaudi</italic> Merozoite Surface Protein 1 (MSP1) antigen allowing direct analysis of the response of anti-<italic>Plasmodium</italic> B cells. Importantly, responses were triggered in chimeric mice carrying low frequencies (~1%) of anti-MSP1 B cells and using the natural route of <italic>P. chabaudi</italic> infection i.e. via mosquito bite. Thus, the authors have utilised a carefully designed, relevant and informative model for this study.</p><p>The authors demonstrate that a population of B cells with an AMB-phenotype is generated but that this population does not persist long-term. It would be important to confirm that these are not GC B cells (see point 3, below). It is also apparent that an FCRL5<sup>hi</sup> population of conventional memory B cells does persist, providing new information about AMBs in the context of <italic>Plasmodium</italic> infection. Whilst this main result is an important one, there are a number of issues with the study that do need to be addressed.</p><p>1) MSP1<sub>21</sub> needs to be defined (the 21kDa C-terminal fragment of MSP1).</p><p>2) For clarity it should be pointed out that a recombinant light chain is not required and that most endogenous light chains will pair with the NIMP23 heavy chain to generate a BCR with detectable binding to MSP1. Can any assessment be made of the affinity cut-off for detection with the MSP1 fluorescent probes?</p><p>3) Please explain briefly in the Results section the nature of the MSP1 fluorescent probes.</p><p>4) It is unusual that CD2 has been used to delineate early B-lineage subsets in Figure 1A. Please provide a reference verifying this marker can be used for this purpose.</p><p>5) The decision to separate the anti-MSP1 B cells present on day 35 of the response into 4 populations based solely on CD11b and CD11c staining is confusing. Although around two-thirds of the cells are GC B cells at this time point (Figure 1—figure supplement 2G), it appears that no attempt has been made to exclude GC B cells from the analyses in Figure 2 or the sorting/mRNAseq analysis shown in Figure 3. Why was this not done? Although the AMBs (CD11b<sup>+</sup>, CD11c<sup>+</sup>) are presumably not GC B cells (this needs to be clarified), the &quot;non-AMB&quot; CD11b<sup>-</sup>, CD11c<sup>-</sup> population seems likely to contain many GC B cells as well as potentially other memory B cells. It is unclear how the mRNAseq data are to be meaningfully interpreted in this case. The fact that GC B cells are included in these analyses needs to be clearly indicated and the impact of this on the interpretation of the data spelled out. In particular, it is difficult to see how any meaningful comparison can be made between the gene expression profiles of AMBs and &quot;non-AMBs&quot;.</p><p>6) Please explain more clearly the justification of the genes chosen to display in Figure 3. In the Materials and methods section it mentioned that &quot;top 50 most up and down regulated gene heat maps&quot; were produced and then that &quot;Significant selected marker genes were used to produce separate heat maps split by functional annotation.&quot; Are the &quot;Top 50&quot; gene sets shown anywhere? And are the &quot;heat maps split by functional annotation&quot; shown in Figure 3 a subset of those in the &quot;Top 50&quot; gene sets? If the answer to both these questions is no, then the reference to these &quot;Top 50&quot; sets should be removed.</p><p>8) In addition, an indication of what the units on the heat map scale are is required. Is this a z-score or log2-fold change or something else?</p><p>7) The data in Figure 4 showing a transient population of CD11b<sup>+</sup> CD11c<sup>+</sup> B cells appearing 1 day after challenge with MSP1 protein is of dubious relevance to the generation/survival of AMBs. There is no way in which these cells could be described as any type of memory B cell. These data are misleading and should be removed.</p><p>8) In the legend for Figure 5I, the first &quot;MSP1<sub>21</sub>-specific B cells&quot; should be removed.</p><p>9) The lengthy discussion about FCRL5 being used to identify the MSP1<sub>21</sub>-specific B<sub>mem</sub> cells was somewhat distracting/confusing in relation to that study's focus on AMBs. It subsequently became clear that it was the marker used to sort the B<sub>mem</sub>. As it is not a well described marker for memory B cells it did need to be justified but an addition to line 325 at the end of FCRL5 Results section, &quot;… FCLR5 identifies <italic>P. chabaudi</italic>-specific B<sub>mem</sub>&quot; indicating that it was subsequently used as a marker to sort on the B<sub>mem</sub> cells, would make the reason for the focus on FCRL5 more clear.</p><p>10) In subsection “<italic>Plasmodium</italic>-specific B<sub>mem</sub> express high levels of FCRL5” and subsection “Mice” the authors refer to FCRL5 (and CD80) as markers of &quot;antigen-experienced B cells.&quot; Since GC B cells and plasma cells are also antigen experienced B cells this statement needs to be made less general so as it applies to just AMBs and B<sub>mem</sub> cells.</p><p><italic>Reviewer #3:</italic> </p><p>The authors generate ki mice that express the heavy chain gene of a previously reported hybridma antibody with reactivity to the <italic>Plasmodium chabaudi</italic> blood stage surface protein, MSP1. Surprisingly, 60% of all B cells in this model bind MSP1 with only the heavy chain ki allele. B cell numbers appear normal, but the high frequency of MSP1-reactive B cells suggests that the heavy chain alone mediates antigen binding. A much less likely explanation may be that the repertoire is biased towards usage of a restricted light chain set and therefore might be highly clonal.</p><p>Unfortunately, I cannot find information on the gene and SHM load, but it is likely mutated. It is also unclear how strongly the naïve cells react to MSP1. A better description and discussion of the ki model is necessary to allow the reader to better judge the findings related to the development of AMBs and to support the physiological relevance of the model and findings. One way of demonstrating this may be to assess the response of the non-ki cells in the transfer model.</p><p>The authors state that they developed the model to study the formation of AMBs in response to mosquito-mediated <italic>P. chabaudi</italic> infection. AMBs have been described in humans. There is a debate as to whether AMBs represent exhausted/non-functional cells or whether they actively contribute to the immune response. In malaria, the latter is supported by the fact that they show signs of proliferation, CSR, and antibody secretion, but definite proof is difficult to obtain in humans.</p><p>Using a transfer model of the MSP1-specific B cells to obtain more physiological numbers of antigen-specific naïve B cells, the authors demonstrate that a MSP1-specific B cell population resembling human AMBs transiently develops in their model and also after MSP1 immunization. The evidence is based on thorough phenotypic and transcriptome analyses, which reveal a plasmablast-like signature suggesting that the cells are activated, short-lived B cells that actively participate in the immune response. Classical memory B cells are also generated in the model and persist after resolution of the infection. These cells express high levels of FCRL5, which established FCRL5 as a marker for memory B cells in this model.</p><p>Technically, this is a very nice study, which demonstrates that AMBc develop also in a mouse model of malaria after mosquito transmission. The findings provide additional support for the notion that these cells actively participate in the response, but unfortunately there is no direct evidence. Do these cells secrete antibodies against the parasite? What about the phenotype of the endogenous B cells in the model? Is the development of AMBs linked to the chronicity of the response and blood stage parasitemia independent of the antigen or ki gene and presumably high affinity of the antibodies? What is the cellular origin of the cells? Do they develop in GCs?</p><p>It is not relevant to answer all questions in the manuscript, but some clear evidence for the function/role of AMBs should be provided to advance over previous descriptive studies in humans. The model should allow the authors to address these important questions.</p><p><italic>Reviewer #4:</italic></p><p>In this manuscript the authors present a rigorous analysis of the impact of <italic>P. chabaudi</italic> infection in mice on antigen-specific (MSP1<sub>21</sub>-specific) B cells from IgH knock-in mice. The authors interpret their data in the context of the documented expansion in humans of what have been termed atypical memory B cells abbreviated here as AMBs. Indeed, defining AMBs in mice as CD11b<sup>+</sup> CD11c<sup>+</sup> FcRL5<sup>+</sup> CD21LO the authors observe increases in the numbers of MSP1<sub>21</sub>-specific B cells with these markers following infection and claim that the infection generated antigen-specific human-like AMB. The problem is that in mice (but not in humans) FcRL5 expression is a discrete/unique marker of marginal zone B cells and B-1a and B-1b cells (often referred to as innate-like B cells) (Davis, (2015); Won et al., (2006)). Thus, by Occam's razor it's fair to assume that authors are describing the impact of infection on marginal zone and B1 B cells. The authors only comment on the expression of FcRL5 in marginal B cells obliquely in the Discussion section.</p><p>I believe it is fair to say that the relationship, if any, between B cells in mice that express T-bet (termed age-related B cells or ABCs) and human atypical B cells (also referred to as tissue-like memory B cells) is not established (Portugal et al., 2017), nor are the identities of unusual B cell populations between all human chronic infections and in autoimmunity. Thus, it would seem to be premature to relate the findings here to an aggregate B cell phenotype in humans particularly when the authors have chosen a discrete/unique marker of mouse innate-like B cells to define AMB. I believe the data here merit publication but as a study of marginal zone and B1 B cells not as a model of human atypical memory B cells.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.39800.023</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>[…] 1) MSP1<sub>21</sub> needs to be defined (the 21kDa C-terminal fragment of MSP1).</p></disp-quote><p>We have corrected this, please see the Introduction.</p><disp-quote content-type="editor-comment"><p>2) For clarity it should be pointed out that a recombinant light chain is not required and that most endogenous light chains will pair with the NIMP23 heavy chain to generate a BCR with detectable binding to MSP1. Can any assessment be made of the affinity cut-off for detection with the MSP1 fluorescent probes?</p></disp-quote><p>This statement has been added to the text, subsection “Generation of an immunoglobulin heavy chain knock-in transgenic mouse model to study <italic>Plasmodium</italic>-specific B cell responses.</p><disp-quote content-type="editor-comment"><p>3) Please explain briefly in the Results section the nature of the MSP1 fluorescent probes.</p></disp-quote><p>A brief explanation of the probe has now been added to the Results section.</p><disp-quote content-type="editor-comment"><p>4) It is unusual that CD2 has been used to delineate early B-lineage subsets in Figure 1A. Please provide a reference verifying this marker can be used for this purpose.</p></disp-quote><p>The following references have been added to the Results section and to the reference list:</p><p>Sen, Rosenberg and Burakoff 1990.</p><p>Young et al., 1994</p><disp-quote content-type="editor-comment"><p>5) The decision to separate the anti-MSP1 B cells present on day 35 of the response into 4 populations based solely on CD11b and CD11c staining is confusing. Although around two-thirds of the cells are GC B cells at this time point (Figure 1—figure supplement 2G), it appears that no attempt has been made to exclude GC B cells from the analyses in Figure 2 or the sorting/mRNAseq analysis shown in Figure 3. Why was this not done? Although the AMBs (CD11b<sup>+</sup>, CD11c<sup>+</sup>) are presumably not GC B cells (this needs to be clarified), the &quot;non-AMB&quot; CD11b<sup>-</sup>, CD11c<sup>-</sup> population seems likely to contain many GC B cells as well as potentially other memory B cells. It is unclear how the mRNAseq data are to be meaningfully interpreted in this case. The fact that GC B cells are included in these analyses needs to be clearly indicated and the impact of this on the interpretation of the data spelled out. In particular, it is difficult to see how any meaningful comparison can be made between the gene expression profiles of AMBs and &quot;non-AMBs&quot;.</p></disp-quote><p>We agree with the reviewer that the non-AMB CD11b<sup>-</sup>CD11c<sup>-</sup> at day 35 π represents a complex population very likely including different B-cell subsets. However, our interest rather lies on the AMB CD11b<sup>+</sup>CD11c<sup>+</sup>. We have shown by the PCA analysis (Figure 7), this is clearly a distinctive subset of B cells, strikingly different from all the other subsets analysed in this study, including non-AMB CD11b<sup>-</sup>CD11c<sup>-</sup> as well as conventional B<sub>mem</sub> and naïve B cells. Figure 3K shows that MSP1-specific AMB CD11b<sup>+</sup>CD11c<sup>+</sup> have plasmablasts/plasma cells characteristics, rather than GC. Moreover, as shown in Figure 5G-I, while the majority of MSP1-specific AMB CD11b<sup>+</sup>CD11c<sup>+</sup> express CD80, and, in lower proportion, CD273, MSP1-specific CD38<sup>lo</sup>GL7<sup>hi</sup> GC B cells do not express any of these two memory markers.</p><p>In order to clarify this point better, we have now added an additional Figure 8 to the manuscript, to provide further details of the phenotypical characteristics of MSP1-specific AMB CD11b<sup>+</sup>CD11c<sup>+</sup>. Figure 8C shows that GC B cells (CD38<sup>lo</sup>GL-7<sup>hi</sup>) are contained within the non-AMB CD11b<sup>-</sup>CD11c<sup>-</sup>, while the MSP1-specific AMB CD11b<sup>+</sup>CD11c<sup>+</sup> show no GC surface markers, clearly showing that these AMB are not GC B cells. Moreover, the MSP1-specific GC B cell pool shows low expression of CD11b and CD11c, clearly setting them apart from the MSP1-specific AMB CD11b<sup>+</sup>CD11c<sup>+</sup> subset (Figure 8E). This is summarised in subsection “<italic>Plasmodium</italic>-specific AMB are a distinct short-lived activated B cell subset” and discussed in the Discussion section.</p><p>Therefore, we believe this is sufficient evidence to demonstrate that MSP1-specific AMB CD11b<sup>+</sup>CD11c<sup>+</sup> represent a B-cell subset distinct from GC.</p><p>Nonetheless, we cannot rule out that the MSP1-specific AMB CD11b<sup>+</sup>CD11c<sup>+</sup> might arise from the GC, or even represent a late GC stage/early GC emigrant. This will be the focus of future more extensive studies.</p><disp-quote content-type="editor-comment"><p>6) Please explain more clearly the justification of the genes chosen to display in Figure 3. In the Materials and methods section it mentioned that &quot; top 50 most up and down regulated gene heat maps&quot; were produced and then that &quot; Significant selected marker genes were used to produce separate heat maps split by functional annotation.&quot; Are the &quot;Top 50&quot; gene sets shown anywhere? And are the &quot; heat maps split by functional annotation&quot; shown in Figure 3 a subset of those in the &quot;Top 50&quot; gene sets? If the answer to both these questions is no, then the reference to these &quot;Top 50&quot; sets should be removed.</p></disp-quote><p>The &quot;Top 50&quot; genes was erroneously carried over from older versions of the manuscript. This has now been corrected and removed from the revised manuscript.</p><p>The genes in Figure 3 were chosen based on previous human AMB reports (Supplementary file 1). These genes were previously shown to be either up or downregulated on human AMB. Those showing significant differential expression on MSP1<sub>21</sub>-specific AMB were used to produce separate heatmaps split by functional annotation. This gene selection to produce Figure 3 was further clarified in the Results section, and the Materials and methods section.</p><disp-quote content-type="editor-comment"><p>8) In addition, an indication of what the units on the heat map scale are is required. Is this a z-score or log2-fold change or something else?</p></disp-quote><p>As stated in Materials and methods section “Heatmaps were generated using the regularized log (rlog) transformed count data, scaled per gene using a z-score”.</p><p>The units given in the heatmaps are z-scores of gene abundance, which have the effect of zero-centering the relative change across samples and aids visualisation.</p><disp-quote content-type="editor-comment"><p>7) The data in Figure 4 showing a transient population of CD11b<sup>+</sup> CD11c<sup>+</sup> B cells appearing 1 day after challenge with MSP1 protein is of dubious relevance to the generation/survival of AMBs. There is no way in which these cells could be described as any type of memory B cell. These data are misleading and should be removed.</p></disp-quote><p>Data in Figure 4 shows that MSP1-specific CD11b<sup>+</sup>CD11c<sup>+</sup> AMB cells are induced in response to immunizations. As stated by the reviewer, these cells are short-lived with no functional characteristics of memory B cells. Our argument is that mouse (and quite possibly human) atypical memory B cells are not really “memory” cells, but rather short-lived activated B cells. Therefore, data in Figure 4 provides further support to our argument.</p><p>Also, this result demonstrates that the presence of the pathogen is not required to activate these cells, as a <italic>P. chabaudi</italic>-derived antigen is sufficient to generate them in the context of a specific immunization strategy. Thus, it appears that MSP1-specific CD11b<sup>+</sup>CD11c<sup>+</sup> AMB cells are not a result of aberrant B-cell activation driven by the pathogen, but rather a normal component of the B-cell response in the context of specific signals.</p><p>We have now changed the manuscript to try to emphasize and clarify these points, subsection “Generation of <italic>Plasmodium</italic>-specific AMB in response to immunization”.</p><disp-quote content-type="editor-comment"><p>8) In the legend for Figure 5I, the first &quot;MSP1<sub>21</sub>-specific B cells&quot; should be removed.</p></disp-quote><p>This has been corrected.</p><disp-quote content-type="editor-comment"><p>9) The lengthy discussion about FCRL5 being used to identify the MSP1<sub>21</sub>-specific B<sub>mem</sub> cells was somewhat distracting/confusing in relation to that study's focus on AMBs. It subsequently became clear that it was the marker used to sort the B<sub>mem</sub>. As it is not a well described marker for memory B cells it did need to be justified but an addition to line 325 at the end of FCRL5 Results section, &quot;… FCLR5 identifies P. chabaudi-specific B<sub>mem</sub>&quot; indicating that it was subsequently used as a marker to sort on the B<sub>mem</sub> cells, would make the reason for the focus on FCRL5 more clear.</p></disp-quote><p>The discussion related to FCRL5 as a memory B cell marker has been reduced.</p><disp-quote content-type="editor-comment"><p>10) In subsection “Plasmodium-specific B<sub>mem</sub> express high levels of FCRL5” and subsection “Mice” the authors refer to FCRL5 (and CD80) as markers of &quot;antigen-experienced B cells.&quot; Since GC B cells and plasma cells are also antigen experienced B cells this statement needs to be made less general so as it applies to just AMBs and B<sub>mem</sub> cells.</p></disp-quote><p>This phrase has now been removed.</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>The authors generate ki mice that express the heavy chain gene of a previously reported hybridma antibody with reactivity to the Plasmodium chabaudi blood stage surface protein, MSP1. Surprisingly, 60% of all B cells in this model bind MSP1 with only the heavy chain ki allele. B cell numbers appear normal, but the high frequency of MSP1-reactive B cells suggests that the heavy chain alone mediates antigen binding. A much less likely explanation may be that the repertoire is biased towards usage of a restricted light chain set and therefore might be highly clonal.</p><p>Unfortunately, I cannot find information on the gene and SHM load, but it is likely mutated.</p></disp-quote><p>The degree of SHM in the transgenic heavy chain, which is demonstrated in Figure 1—figure supplement 1, is approximately 88 to 90% of germline. This level of SHM suggests that this particular HC derives from a B cell that underwent affinity maturation by passaging through the GC.</p><disp-quote content-type="editor-comment"><p>It is also unclear how strongly the naïve cells react to MSP1. A better description and discussion of the ki model is necessary to allow the reader to better judge the findings related to the development of AMBs and to support the physiological relevance of the model and findings. One way of demonstrating this may be to assess the response of the non-ki cells in the transfer model.</p></disp-quote><p>As shown in Figure 1E, the frequency of non-Tg B cells that react with the MSP1 probe is at least 100-fold lower than the frequency of Tg B cells that react to the probe. Thus, we interpret the signal from the non-Tg B cells as background. Importantly, this does not change after adoptive transference (Figure 1—figure supplement 1D) and infection-driven activation (<xref ref-type="fig" rid="respfig1">Author response image 1</xref>).</p><fig id="respfig1"><label>Author response image 1.</label><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-39800-resp-fig1-v2"/></fig><disp-quote content-type="editor-comment"><p>[…] The findings provide additional support for the notion that these cells actively participate in the response, but unfortunately there is no direct evidence. Do these cells secrete antibodies against the parasite? What about the phenotype of the endogenous B cells in the model? Is the development of AMBs linked to the chronicity of the response and blood stage parasitemia independent of the antigen or ki gene and presumably high affinity of the antibodies? What is the cellular origin of the cells? Do they develop in GCs?</p><p>It is not relevant to answer all questions in the manuscript, but some clear evidence for the function/role of AMBs should be provided to advance over previous descriptive studies in humans. The model should allow the authors to address these important questions.</p></disp-quote><p>We thank the reviewer for the questions raised from the study. We agree that all of these important questions should be answered. This indeed is the purpose of developing the model. However, our manuscript already contains a vast amount of data, and highlights important points about the characteristics of these cells in this model. The questions posed would constitute a large number of very long-term experiments to answer these points satisfactorily. They will be the subject of a further manuscript. However, we have raised them as important follow-up experiments in the Discussion section.</p><disp-quote content-type="editor-comment"><p>Reviewer #4:</p><p>[…] The problem is that in mice (but not in humans) FcRL5 expression is a discrete/unique marker of marginal zone B cells and B-1a and B-1b cells (often referred to as innate-like B cells) (Davis, (2015); Won et al., (2006)). Thus, by Occam's razor it's fair to assume that authors are describing the impact of infection on marginal zone and B1 B cells. The authors only comment on the expression of FcRL5 in marginal B cells obliquely in the discussion.</p></disp-quote><p>Please, see answer to question 2 below.</p><disp-quote content-type="editor-comment"><p>I believe it is fair to say that the relationship, if any, between B cells in mice that express T-bet (termed age-related B cells or ABCs) and human atypical B cells (also referred to as tissue-like memory B cells) is not established (Portugal et al., 2017), nor are the identities of unusual B cell populations between all human chronic infections and in autoimmunity. Thus, it would seem to be premature to relate the findings here to an aggregate B cell phenotype in humans particularly when the authors have chosen a discrete/unique marker of mouse innate-like B cells to define AMB. I believe the data here merit publication but as a study of marginal zone and B1 B cells not as a model of human atypical memory B cells.</p></disp-quote><p>The initial work characterizing the receptor distribution of FCRL5 (Won et al.,. 2006), was performed on tissues from mice at homeostasis. Up to this point, we are not aware of any published studies performed on immune challenged mice for FCRL5 protein expression by memory B cells. In unpublished data, generated in an independent laboratory from the senior author, we have identified small numbers of class-switched (CS) cells in the spleens of unchallenged mice that lack typical MZ markers. In these separate studies, FCRL5 surface expression overlaps with the expression of memory markers identified by Shlomchik as detailed in the current manuscript. Furthermore, in other preliminary studies, FCRL5 expression also appears to be expressed by class-switched B cells in mice following NP-CGG challenge. Thus, rather than a molecule restricted to innate-like B cells, FCRL5 may serve as a marker/regulator of B lineage cells situated at a peak stage of maturity that are poised for antigen reactivity and terminal differentiation (i.e. Ab secretion).</p><p>Moreover, in order to clarify this point further, we have now added to the manuscript an additional Figure 8 to provide further details of the phenotypical characteristics of MSP1-specific AMB CD11b<sup>+</sup>CD11c<sup>+</sup>. As discussed elsewhere (Baumgarth,2010, Garraud et al., 2012, Zouali and Richard 2011, Pillai et al., 2005), B1 and MZ B cells are CD1d<sup>mid/hi</sup>, CD9<sup>+</sup>, IgM<sup>hi</sup> and CD23<sup>—</sup>. B1 are also CD43<sup>+</sup>, B220<sup>lo</sup>, and may (B1a) or may not (B1b) express CD5. MZ are further characterised by CD22<sup>hi</sup>, CD21/CR2<sup>hi</sup>, and the expression of the lysophospholipid sphingosine-1 phosphate receptor S1P<sub>1</sub>, and the lineage master regulator <italic>Notch2</italic>. Indeed, MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> AMB showed high expression of some markers associated with B1 and/or MZ, including CD5, CD9 and CD43. However, these markers have also been shown to be highly expressed by activated B2 B cells and/or plasma cells (Baumgarth,2010). Studying all these canonical markers, we found no other similarities between B1/MZ and MSP1<sub>21</sub>-specific CD11b<sup>+</sup>CD11c<sup>+</sup> AMB to suggest a relationship between these subsets (Figure 8A). This was further corroborated by flow cytometry analysis (Figure 8B). Moreover, unlike MZ and B1 B cells, MSP1<sub>21</sub>-specific AMB were class-switched and expressed very high levels of IgG (Figure 7D). Nonetheless, B1 B cells have been shown to class-switch and contribute to serum IgG1, IgG2a and IgA to influenza (Baumgarth, 2005), and IgG-producing B1a B cells have been shown to accumulate in the spleen of a mouse model of systemic lupus erythematosus (Enghard, 2010). Therefore, we cannot absolutely rule out the possibility that AMB might represent a particular B1 B cell subset that expands in the spleen and blood in response to <italic>Plasmodium</italic> infection. However, it is important to highlight that in these previous studies (Baumgarth, 2005; Enghard, 2010) the B1a compartment producing IgG was no more than 20% of the total B1a compartment (the other 80% producing IgM). As shown in Figure 8B and Figure 7, the MSP1-specific AMB identified here are IgM<sup>lo</sup> and express very high levels of IgG. This is unlike any other B1 B cells described so far, and rather suggest a GC origin.</p><p>We hope we have clarified this in the text, subsection “<italic>Plasmodium</italic>-specific AMB are a distinct short-lived activated B cell subset” and the Discussion section.</p><p>We used publicly available RNA expression data from an extensive series of experiments defining AMB in humans (summarized in Supplementary file 1) to determine whether these mouse AMB cells have gene expression profiles similar to the human AMB cells. It is true that our FACS analyses on MSP1-specific AMB included a limited number of surface markers based on previous data generated in humans (i.e. CD11b, CD11c, CD80, IgD, IgM, FCRL-5 and CD21). Nonetheless, we performed extensive transcriptome analysis on sorted MSP1-specific AMB. Our conclusion that the cells we identify here resemble human AMB is based on an extensive and deep comparison of the transcriptome of the MSP1-specific AMB identified here with human AMB identified in different infections, including <italic>Plasmodium</italic> and HIV (Please, refer to Supplementary file 1 and Figure 3). Therefore, we do not agree with the reviewer that we arrive at this conclusion only based on the expression of a few surface marker, and believe our analysis is much more robust and that the similarities between MSP1-specific AMB and human AMB are indeed striking.</p></body></sub-article></article>